Other and unspecified rosacea

L12_ROSACEANAS

rosacea: a chronic skin condition characterized by facial redness, small and superficial dilated blood vessels on facial skin, papules, pustules, and swelling.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L71.8, L71.9 Hospital discharge: ICD-9 — 6953A Cause of death: ICD-10 — L71.8, L71.9 Cause of death: ICD-9 — 6953A 2 out of 7 registries used, show all original rules.	3594
4. Check minimum number of events None	3594
5. Include endpoints None	3594
6. Filter based on genotype QC (FinnGen only)	3506

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	L12_ROSACEANAS
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L71[8-9]
HD_ICD_9	6953A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L71[8-9]
COD_ICD_9	6953A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified rosacea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18076	11991	6018
Only index persons	17470	11760	5710
Unadjusted period prevalence (%)
Whole population	0.28	0.34	0.17
Only index persons	0.36	0.43	0.22
Median age at first event (years)
Whole population	54.55	52.63	58.42
Only index persons	54.37	52.49	58.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3506	2479	1027
Unadjusted period prevalence (%)	0.76	0.88	0.47
Median age at first event (years)	55.70	53.07	62.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3594: Matched controls
35940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D06BX01

ATC

metronidazole; topical

32.3

307.7

2445

2224

L71

ICD-10 Finland

Rosacea

18.2

307.7

521

332

J01AA04

ATC

lymecycline; systemic

10.4

307.7

1594

2549

L71.9

ICD-10 Finland

Rosacea, unspecified

246.0

307.7

2264

247

J01AA07

ATC

tetracycline; systemic

7.6

307.7

1534

3206

D10BA01

ATC

isotretinoin; oral

9.9

307.7

734

905

L71.8

ICD-10 Finland

Other rosacea

462.2

307.7

1879

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

6.1

307.7

819

1657

E0000UV, ,

ATC

3.5

296.2

2176

10867

D10AX03

ATC

azelaic acid; topical

5.5

277.3

605

1276

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.7

277.2

1261

4629

XQ802

NOMESCO Finland

Epicutan test

7.0

269.4

440

700

L71.0

ICD-10 Finland

Perioral dermatitis

11.7

192.4

201

181

XQ848

NOMESCO Finland

Dermatological photography

7.8

186.6

267

364

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.8

184.6

655

1986

L70.0

ICD-10 Finland

Acne vulgaris

15.4

179.2

158

107

E000001, ,

ATC

2.9

171.5

1054

4447

L57.0

ICD-10 Finland

Actinic keratosis

3.8

167.7

581

1727

XQ800

NOMESCO Finland

Prick test

3.6

133.2

490

1505

D07AB02

ATC

hydrocortisone butyrate; topical

2.4

133.0

1365

7256

L73.8

ICD-10 Finland

Other specified follicular disorders

21.7

127.4

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

10.4

125.9

141

140

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

7.5

124.5

183

256

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

7.2

122.4

187

273

D07AC01

ATC

betamethasone; topical

2.3

120.6

1580

9230

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

106.9

621

2479

TQW80

NOMESCO Finland

Local dermatologic skincare

5.8

99.7

187

336

H01.0

ICD-10 Finland

Blepharitis

3.4

97.3

383

1219

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.5

91.0

182

347

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

89.9

1755

11547

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.2

88.6

1003

5387

D07AC13

ATC

mometasone; topical

2.1

88.6

1230

7147

L71.1

ICD-10 Finland

Rhinophyma

220.2

83.7

ZXC12

NOMESCO Finland

Pulse colorlaser

24.5

81.8

D07AB08

ATC

desonide; topical

2.6

81.4

520

2160

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.8

80.2

151

272

D07XC01

ATC

betamethasone; topical

2.5

78.7

554

2410

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.9

78.4

245

667

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.4

75.9

597

2731

S01GX01

ATC

cromoglicic acid; ophthalmic

2.1

75.2

910

4970

D07AA02

ATC

hydrocortisone; topical

2.3

71.2

607

2870

H02AB06

ATC

prednisolone; systemic

1.9

71.2

1840

12940

XQ845

NOMESCO Finland

Dermatoscopy

5.9

70.8

129

225

L73.2

ICD-10 Finland

Hidradenitis suppurativa

17.0

68.7

L04AX01

ATC

azathioprine; systemic

3.6

68.4

233

672

ZXC50

NOMESCO Finland

Cryotherapy

4.5

68.1

170

391

D07AD01

ATC

clobetasol; topical

2.1

65.2

719

3765

L20.0

ICD-10 Finland

Besnier prurigo

2.8

64.0

358

1383

R06AX27

ATC

desloratadine; oral

1.9

63.4

1196

7542

E0001A1, ,

ATC

5.3

63.0

128

247

E000002, ,

ATC

2.4

62.7

491

2229

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.7

62.4

357

1395

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

8.5

60.9

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.5

59.1

212

632

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

7.2

58.9

125

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

58.6

1115

7016

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

58.0

1240

8083

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

14.6

57.9

D10AF01

ATC

clindamycin; topical

3.1

56.6

245

820

L73.9

ICD-10 Finland

Follicular disorder, unspecified

16.2

56.4

L93.0

ICD-10 Finland

Discoid lupus erythematosus

10.3

55.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

53.6

412

1848

R06AE07

ATC

cetirizine; oral

1.7

53.6

1709

12409

L21.0

ICD-10 Finland

Seborrhoea capitis

7.2

53.4

114

S29

ICPC

Skin symptom/complaint other

1.9

51.8

746

4265

H00.1

ICD-10 Finland

Chalazion

3.3

51.3

201

633

D02AX

ATC

Other emollients and protectives

3.8

51.3

162

443

TQW99

NOMESCO Finland

Other minor procedure on skin

3.1

51.2

222

743

UJF32

NOMESCO Finland

Coloscopy

1.8

50.9

972

6075

D02AE01

ATC

carbamide; topical

2.7

50.7

295

1159

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.8

50.4

271

1022

J01DB01

ATC

cefalexin; oral

2.0

49.3

3007

25921

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.0

48.9

227

790

P01BA02

ATC

hydroxychloroquine; oral

2.4

48.4

378

1705

D11AH02

ATC

pimecrolimus; topical

11.5

48.3

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.9

47.9

760

4471

L04AX03

ATC

methotrexate; systemic

2.2

47.5

421

2004

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

15.5

46.0

J02AC01

ATC

fluconazole; systemic

1.6

44.1

1594

11757

S18

ICPC

Laceration/cut

1.6

43.6

1596

11800

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

42.1

856

5404

L04AA06

ATC

mycophenolic acid; systemic

4.6

41.8

101

226

SPAT1153

SPAT

Removal of sutures

1.7

41.2

1116

7614

L70.9

ICD-10 Finland

Acne, unspecified

13.1

40.8

E000006, ,

ATC

2.4

38.3

284

1248

J01AA02

ATC

doxycycline; systemic

1.7

38.2

2818

24371

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.5

38.2

262

1112

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

37.8

1543

11579

R06AE09

ATC

levocetirizine; oral

1.9

37.5

578

3345

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.0

37.3

169

580

J04BA02

ATC

dapsone; oral

9.9

36.5

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.4

36.1

211

L50.3

ICD-10 Finland

Dermatographic urticaria

4.0

35.8

101

255

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.1

35.5

150

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

35.4

944

6371

L30.3

ICD-10 Finland

Infective dermatitis

3.0

35.2

157

534

D05AX52

ATC

calcipotriol, combinations; topical

2.5

35.1

222

906

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.2

33.7

138

A02BC05

ATC

esomeprazole; systemic

1.5

33.4

1461

11045

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

33.2

427

2322

E000007, ,

ATC

2.4

33.1

228

969

R03AC02

ATC

salbutamol; inhalant

1.5

32.8

1968

15898

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

32.3

2361

19868

S01XA18

ATC

ciclosporin; ophthalmic

6.2

32.2

M79.6

ICD-10 Finland

Pain in limb

1.5

31.9

1502

11503

D05BB02

ATC

acitretin; oral

3.6

31.6

104

293

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

31.5

650

4083

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.6

31.3

106

304

S99

ICPC

Skin disease other

3.7

30.9

100

278

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

30.8

620

3864

L30.8

ICD-10 Finland

Other specified dermatitis

3.2

30.8

123

392

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

30.7

277

1320

A02BC02

ATC

pantoprazole; systemic

1.5

30.7

2393

20301

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

30.6

1436

10959

R06.0

ICD-10 Finland

Dyspnoea

1.6

30.2

906

6256

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.3

30.1

189

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.6

29.9

275

H10.4

ICD-10 Finland

Chronic conjunctivitis

5.1

29.6

123

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

29.5

1144

8363

M25.5

ICD-10 Finland

Pain in joint

1.5

29.2

1169

8600

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

29.0

1368

10416

J05AB01

ATC

aciclovir; systemic

1.6

29.0

803

5431

A02BC01

ATC

omeprazole; systemic

1.6

28.6

932

6545

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

28.2

2535

21936

L70

ICD-10 Finland

Acne

4.9

28.1

125

SPAT1310

SPAT

Counselling related to known health issue

1.5

27.8

1065

7744

J01FF01

ATC

clindamycin; systemic

1.6

27.8

928

6546

J01DA01

ATC

[U] cefalexin

1.5

27.8

2162

18132

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

27.7

642

4147

A02BC03

ATC

lansoprazole; oral

1.5

27.4

985

7060

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

27.3

458

2704

S21

ICPC

Skin texture symptom/complaint

1.8

27.2

489

2945

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

27.2

999

7194

L72.1

ICD-10 Finland

Trichilemmal cyst

2.4

27.0

184

777

CBB00

NOMESCO Finland

Excision of chalazion

4.2

26.8

171

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

26.8

1034

7521

E000003, ,

ATC

2.5

26.3

172

713

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

26.1

323

1728

S08

ICPC

Skin colour change

2.3

26.0

202

905

SPAT1301

SPAT

No procedures

1.5

25.9

1011

7361

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

25.7

1269

9688

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

25.6

367

2061

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

25.5

294

1536

Z01.2

ICD-10 Finland

Dental examination

1.5

25.2

1569

12516

H02AB04

ATC

methylprednisolone; systemic

1.7

25.1

515

3214

F29

ICPC

Eye symptom/complaint other

1.9

24.9

339

1872

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

6.2

24.9

B07.9

ICD-10 Finland

Verruca simplex

2.7

24.7

137

524

J01FA01

ATC

erythromycin; systemic

1.7

24.6

489

3024

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

24.5

183

806

D11AH01

ATC

tacrolimus; topical

4.8

24.3

117

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

24.1

1324

10287

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.1

24.0

H00.00

ICD-10 Finland

Hordeolum

2.4

23.9

174

758

N02AX02

ATC

tramadol; systemic, rectal

1.4

23.7

1424

11245

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

23.5

919

6671

L04AD01

ATC

ciclosporin; systemic

3.5

23.3

232

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

23.3

1919

16023

R05

ICD-10 Finland

Cough

1.6

23.2

732

5068

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.3

23.2

142

SPAT1260

SPAT

Consultation of another employee

1.6

23.1

579

3797

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.1

23.1

237

1185

R06AX22

ATC

ebastine; oral

1.6

23.1

636

4267

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

23.1

423

2554

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

5.1

23.1

R60.0

ICD-10 Finland

Localized oedema

1.8

23.0

402

2395

L70.8

ICD-10 Finland

Other acne

30.2

22.8

L01XX05

ATC

hydroxycarbamide; oral

4.4

22.7

132

S01GX05

ATC

lodoxamide; ophthalmic

3.7

22.5

199

J01FA06

ATC

roxithromycin; oral

1.4

22.5

1384

10945

R01AD12

ATC

fluticasone furoate; nasal

1.5

22.4

1129

8601

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

22.4

237

1199

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

22.3

432

2648

SFA10

NOMESCO Finland

One-surface restoration

1.4

22.1

1873

15654

SPAT1263

SPAT

Sampling

1.4

22.1

1371

10850

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

5.5

21.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

21.9

875

6364

R03DC03

ATC

montelukast; oral

1.6

21.7

604

4058

G47.3

ICD-10 Finland

Sleep apnoea

1.5

21.6

721

5049

H15.1

ICD-10 Finland

Episcleritis

3.5

21.4

206

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.3

21.4

164

730

N02BE01

ATC

paracetamol; systemic, rectal

1.6

21.4

3125

28856

D06BB10

ATC

imiquimod; topical

2.2

21.1

180

838

H16.9

ICD-10 Finland

Keratitis, unspecified

3.5

21.1

213

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.5

21.0

115

L50.9

ICD-10 Finland

Urticaria, unspecified

2.4

21.0

146

623

6953A

ICD-9 Finland

Erythematous conditions, Rosacea[ROSACEA]

+∞

20.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

20.8

929

6897

R01AD58

ATC

fluticasone, combinations; nasal

1.5

20.7

870

6379

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.9

20.7

155

H02AB07

ATC

prednisone; oral

1.7

20.7

459

2915

N03AX12

ATC

[U] gabapentin; oral

1.6

20.7

561

3744

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

4.1

20.7

142

L50.8

ICD-10 Finland

Other urticaria

3.2

20.6

261

K30

ICD-10 Finland

Functional dyspepsia

1.7

20.5

397

2432

SFA20

NOMESCO Finland

Two-surface restoration

1.4

20.3

2020

17234

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.9

20.3

338

R01AD09

ATC

mometasone; nasal

1.4

20.2

1587

13018

F03

ICPC

Eye discharge

2.0

20.1

240

1267

J01FA10

ATC

azithromycin; systemic

1.4

19.9

1986

16928

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

19.9

332

1950

SDA03

NOMESCO Finland

Periodontal treatment

1.4

19.9

1362

10909

K02.1

ICD-10 Finland

Caries of dentine

1.4

19.8

1992

16996

J01MA02

ATC

ciprofloxacin; systemic

1.4

19.8

1225

9637

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

19.8

617

4248

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

19.7

758

5455

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

19.7

1194

9360

SPAT1312

SPAT

General health counselling

1.4

19.5

1010

7692

L01

ICPC

Neck symptom/complaint

1.6

19.5

546

3669

H16.0

ICD-10 Finland

Corneal ulcer

2.1

19.5

177

846

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

19.4

430

2728

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

19.3

270

1503

G44.2

ICD-10 Finland

Tension-type headache

1.6

19.2

490

3219

D45

ICD-10 Finland

Polycythaemia vera

4.7

19.1

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.2

19.1

232

L04AB04

ATC

adalimumab; parenteral

2.9

19.0

328

R51.80

ICD-10 Finland

Headache

1.6

18.9

539

3632

L04AA01

ATC

[U] ciclosporin

3.6

18.9

170

L30.0

ICD-10 Finland

Nummular dermatitis

2.4

18.9

136

590

L17

ICPC

Foot/toe symptom/complaint

1.4

18.9

933

7040

J02AC02

ATC

itraconazole; systemic

1.5

18.8

618

4301

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

18.6

130

556

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

18.6

1189

9386

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

18.5

623

4353

ZY010

NOMESCO Finland

Hospital outpatient

2.1

18.5

176

856

L03

ICPC

Low back symptom/complaint

1.4

18.5

929

7027

S01

ICPC

Pain/tenderness of skin

2.2

18.5

163

770

C01CA24

ATC

epinephrine; parenteral

1.9

18.2

231

1245

S06

ICPC

Rash localized

2.1

18.2

184

916

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

18.1

223

1191

A07EA06

ATC

budesonide; oral, local oral

2.3

18.0

133

583

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

18.0

365

2261

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

18.0

1469

12051

I73.0

ICD-10 Finland

Raynaud syndrome

3.1

18.0

236

R06AX13

ATC

loratadine; oral

1.6

17.6

524

3561

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

17.6

301

1778

J05AB11

ATC

valaciclovir; oral

1.6

17.6

490

3281

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

17.5

261

1480

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

17.5

434

2829

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

17.5

1646

13787

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

17.5

212

1126

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

17.4

233

1277

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.6

17.4

373

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

17.2

234

1289

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

17.2

338

2075

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

2.7

17.2

352

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.1

17.2

237

R42

ICD-10 Finland

Dizziness and giddiness

1.5

17.0

710

5176

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

17.0

198

1037

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

16.9

233

1290

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

16.9

344

2133

D06BX02

ATC

ingenol mebutate; topical

3.7

16.7

146

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.2

16.7

215

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

16.7

254

1450

N03AX16

ATC

[U] pregabalin

1.4

16.6

758

5614

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

5.8

16.6

127

Kela drug reimbursment

Transplant complication

3.5

16.6

161

M54.5

ICD-10 Finland

Low back pain

1.4

16.5

1198

9608

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

16.5

833

6285

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.9

16.4

225

1244

R06AX26

ATC

fexofenadine; oral

1.8

16.3

251

1437

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

16.3

176

897

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

16.3

1582

13261

A01AB09

ATC

miconazole; local oral

1.8

16.3

272

1596

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.7

16.2

317

-1, ,

NOMESCO Finland

1.4

16.2

1065

8403

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

16.2

158

777

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

16.1

1664

14070

Z00.0

ICD-10 Finland

General medical examination

1.5

16.1

592

4205

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.0

797

5993

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.4

16.0

107

449

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

16.0

153

746

KMAK, ,

NOMESCO Finland

1.3

16.0

1737

14789

Z3231

NOMESCO Finland

Registered nurse

1.4

15.9

840

6382

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

15.9

198

1061

S01GX08

ATC

ketotifen; ophthalmic

2.0

15.9

165

830

M01AH05

ATC

etoricoxib; oral

1.3

15.8

2123

18631

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

15.7

229

1290

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.2

15.7

138

651

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

15.7

118

522

P01AB01

ATC

metronidazole; oral, rectal

1.3

15.7

1364

11229

N06AX11

ATC

mirtazapine; oral

1.4

15.6

1100

8767

D01AE16

ATC

amorolfine; topical

1.6

15.5

370

2385

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

15.5

369

2378

D06AX01

ATC

fusidic acid; topical

1.7

15.4

292

1774

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

15.3

391

R05

ICPC

Cough

1.4

15.3

772

5812

L43.8

ICD-10 Finland

Other lichen planus

2.9

15.3

259

J01DA09

ATC

[U] cefadroxil

1.4

15.2

863

6634

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

3.3

15.2

166

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

6.1

15.1

C07AA05

ATC

propranolol; systemic

1.4

15.1

684

5053

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

15.0

248

1451

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.7

15.0

129

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.2

14.9

183

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

14.9

142

692

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

14.9

126

586

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

14.8

902

7010

L20

ICD-10 Finland

Atopic dermatitis

2.4

14.8

102

435

UKC02

NOMESCO Finland

Cystoscopy

1.5

14.8

427

2879

L40.8

ICD-10 Finland

Other psoriasis

4.4

14.7

D05AX02

ATC

calcipotriol; topical

2.2

14.7

122

563

R01AD08

ATC

fluticasone; nasal

1.4

14.6

965

7592

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.9

14.6

176

932

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

14.6

297

1840

L13

ICPC

Hip symptom/complaint

1.5

14.5

580

4182

R52.9

ICD-10 Finland

Pain, unspecified

1.6

14.4

311

1956

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

14.3

139

682

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.3

2405

21640

M48.0

ICD-10 Finland

Spinal stenosis

1.6

14.2

356

2321

S87

ICPC

Dermatitis/atopic eczema

2.6

14.1

334

A02BA02

ATC

ranitidine; systemic

1.5

14.1

581

4209

D82

ICPC

Teeth/gum disease

1.3

14.0

1197

9783

SCA02

NOMESCO Finland

Preventive oral health care

1.6

14.0

300

1883

M04AA01

ATC

allopurinol; systemic

1.6

13.9

326

2093

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.4

13.9

404

SPAT1058

SPAT

PEF monitoring instruction

1.7

13.9

257

1553

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

13.7

809

6241

A07EC02

ATC

mesalazine; oral, rectal

1.9

13.7

170

910

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

13.7

190

1055

F02

ICPC

Red eye

2.0

13.7

142

715

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

13.6

259

1576

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

13.5

608

4474

L20.8

ICD-10 Finland

Other atopic dermatitis

3.3

13.5

148

K50.8

ICD-10 Finland

Other Crohn disease

3.0

13.5

189

R53

ICD-10 Finland

Malaise and fatigue

1.4

13.5

738

5623

M79.1

ICD-10 Finland

Myalgia

1.5

13.4

482

3399

M03BX02

ATC

tizanidine; oral

1.3

13.4

2127

18891

Z94.0

ICD-10 Finland

Kidney transplant status

3.8

13.4

106

J01EA01

ATC

trimethoprim; systemic

1.4

13.4

848

6615

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

3.1

13.4

185

L63.8

ICD-10 Finland

Other alopecia areata

25.8

13.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

13.3

344

2260

S04

ICPC

Lump/swelling localized

1.6

13.3

317

2043

L04AD02

ATC

tacrolimus; systemic

3.9

13.2

C03DA01

ATC

spironolactone; oral

1.6

13.2

327

2126

XPX04

NOMESCO Finland

Angioscopy

5.7

13.2

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

13.2

327

2127

G50.1

ICD-10 Finland

Atypical facial pain

2.6

13.2

281

M01AE02

ATC

naproxen; oral, rectal

1.3

13.1

1888

16527

L40

ICD-10 Finland

Psoriasis

2.7

13.1

264

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

13.1

137

692

L56.4

ICD-10 Finland

Polymorphous light eruption

4.8

13.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

13.0

410

2812

R03BA02

ATC

budesonide; inhalant

1.4

13.0

575

4217

L08

ICPC

Shoulder symptom/complaint

1.4

12.9

686

5197

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.9

554

4042

R21

ICPC

Throat symptom/complaint

1.4

12.9

643

4818

L01BA01

ATC

methotrexate; systemic

2.1

12.9

125

614

F01

ICPC

Eye pain

2.3

12.9

437

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.9

12.9

200

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.0

12.9

184

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

12.8

229

1369

G03HB01

ATC

cyproterone and estrogen; oral

1.6

12.8

325

2124

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

12.8

372

2508

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

12.8

875

6900

C03CA01

ATC

furosemide; systemic

1.4

12.8

764

5898

A98

ICPC

Health maint/preventive medicine

2.0

12.7

3466

33518

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

12.7

123

604

J01FA09

ATC

clarithromycin; systemic

1.3

12.7

1021

8248

L15

ICPC

Knee symptom/complaint

1.4

12.7

745

5735

XQ899

NOMESCO Finland

Other assessment of skin

5.1

12.7

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.8

12.6

180

1008

N06AX21

ATC

duloxetine; oral

1.5

12.6

387

2641

H93.1

ICD-10 Finland

Tinnitus

1.7

12.5

217

1287

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

12.5

392

2686

D05AX03

ATC

calcitriol; topical

3.2

12.5

156

L85.3

ICD-10 Finland

Xerosis cutis

3.6

12.4

112

K07.60

ICD-10 Finland

Snapping jaw

1.8

12.2

181

1025

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

12.2

241

1482

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.2

1429

12140

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

12.2

1005

8140

R08

ICPC

Nose symptom/complaint other

2.1

12.2

111

533

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.2

12.2

106

500

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.9

12.1

149

796

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

12.0

418

H16.2

ICD-10 Finland

Keratoconjunctivitis

3.9

12.0

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.0

966

7794

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

12.0

425

R13

ICD-10 Finland

Dysphagia

1.7

12.0

211

1258

R03BA01

ATC

beclometasone; inhalant

1.5

12.0

441

3123

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

11.9

218

1312

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

11.9

154

836

SPAT1325

SPAT

Vaccination

1.3

11.9

964

7782

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

11.9

239

1476

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.8

779

6100

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.2

11.8

100

467

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

11.8

454

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

11.7

203

1204

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

11.7

876

6990

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.7

1252

10495

C09CA06

ATC

candesartan; oral

1.4

11.6

734

5706

QXA05

NOMESCO Finland

Skin division, unspecified location

5.5

11.6

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

11.6

149

808

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

11.6

256

1620

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.3

11.5

374

R03AC03

ATC

terbutaline; inhalant

1.5

11.5

442

3153

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.5

449

3214

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.3

11.5

R96

ICPC

Asthma

1.6

11.4

303

2001

D07XB05

ATC

dexamethasone; topical

2.3

11.4

382

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

11.4

258

1641

R03BA08

ATC

ciclesonide; inhalant

1.6

11.3

285

1860

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

5.1

11.3

R01AD01

ATC

beclometasone; nasal

1.4

11.2

501

3674

N06AX16

ATC

venlafaxine; oral

1.4

11.2

463

3349

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

11.2

220

1352

S01GX02

ATC

levocabastine; ophthalmic

1.7

11.1

196

1168

M01AC06

ATC

meloxicam; systemic, rectal

1.3

11.1

1168

9749

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.1

1144

9526

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

11.0

1347

11460

C07AB07

ATC

bisoprolol; oral

1.3

11.0

1412

12085

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

11.0

260

1672

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.3

11.0

357

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.5

11.0

277

R02

ICPC

Shortness of breath/dyspnoea

1.5

11.0

374

2607

L84

ICD-10 Finland

Corns and callosities

2.1

10.9

104

508

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.2

10.9

429

A01AB04

ATC

amphotericin B; local oral

1.9

10.9

136

731

L04AB01

ATC

etanercept; parenteral

2.6

10.9

231

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.8

569

4290

R51

ICD-10 Finland

Headache

1.7

10.8

179

1049

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

10.8

1561

13546

R01AD11

ATC

triamcinolone; nasal

1.6

10.8

277

1816

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

10.8

672

5209

A46

ICD-10 Finland

Erysipelas

1.5

10.7

384

2701

R74

ICPC

Upper respiratory infection acute

1.3

10.7

1009

8293

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.4

10.7

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

10.7

119

616

J45

ICD-10 Finland

Asthma

1.5

10.6

326

2224

SFA30

NOMESCO Finland

Three-surface restoration

1.3

10.6

1364

11663

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

10.6

636

4900

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

5.3

10.6

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.0

10.6

156

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

10.5

144

797

L60.0

ICD-10 Finland

Ingrowing nail

1.9

10.5

124

654

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

10.5

120

626

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

10.5

359

2503

ZXC10

NOMESCO Finland

Use of laser

2.4

10.5

308

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.6

10.5

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.1

10.5

141

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

10.4

171

999

L12

ICPC

Hand/finger symptom/complaint

1.4

10.4

487

3598

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

10.4

762

6044

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.6

10.4

236

C10AC01

ATC

colestyramine; oral

2.2

10.4

411

SPAT1216

SPAT

Assessment of functional ability

1.4

10.4

422

3041

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

10.4

463

3393

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

7.7

10.4

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

10.4

508

3785

D07AB01

ATC

clobetasone; topical

2.0

10.4

102

505

D02

ICPC

Abdominal pain epigastric

1.7

10.3

189

1141

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

10.3

473

H13

ICPC

Plugged feeling ear

1.4

10.3

536

4036

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

10.3

122

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.9

10.3

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.5

10.2

262

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

10.2

156

893

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

10.2

145

812

F16

ICPC

Eyelid symptom/complaint

1.8

10.2

159

916

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

10.2

273

1807

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.0

10.2

114

591

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.2

566

4307

H57.1

ICD-10 Finland

Ocular pain

1.9

10.1

119

627

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.1

522

3921

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

10.1

993

8196

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

10.1

532

4010

S15

ICPC

Foreign body in skin

1.7

10.1

187

1131

S88

ICPC

Dermatitis contact/allergic

2.4

10.1

270

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

10.1

160

927

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

10.1

643

4997

SPAT1009

SPAT

Measurement of intraocular pressure

2.9

10.1

166

R04.0

ICD-10 Finland

Epistaxis

1.7

10.0

199

1225

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

10.0

340

L66.1

ICD-10 Finland

Lichen planopilaris

40.2

10.0

R03BA05

ATC

fluticasone; inhalant

1.4

9.9

556

4232

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.9

407

2939

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

9.9

176

1053

J01CA04

ATC

amoxicillin; systemic

1.3

9.9

2756

25743

N06AX26

ATC

vortioxetine; oral

1.6

9.8

212

1334

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.0

9.8

136

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.8

307

2103

SBB10

NOMESCO Finland

Dental impressions

1.7

9.8

186

1133

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

9.8

177

1064

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

9.8

216

1367

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

9.8

491

3672

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.8

9.8

M01CB01

ATC

sodium aurothiomalate; parenteral

2.8

9.7

169

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.3

9.7

312

G01AA10

ATC

clindamycin; vaginal

1.4

9.7

517

3903

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

9.7

856

6961

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.3

9.7

106

SPAT1229

SPAT

Assessment of need for aid

1.6

9.7

210

1323

D01BA02

ATC

terbinafine; oral

1.3

9.7

731

5820

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

9.6

701

5550

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

9.6

412

3000

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.3

9.6

302

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

8.4

9.5

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.7

9.5

188

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.8

9.5

160

M77.4

ICD-10 Finland

Metatarsalgia

1.6

9.5

196

1219

A07AA02

ATC

nystatin; oral

1.7

9.5

167

996

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

9.5

231

1496

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

9.5

280

1893

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.7

9.5

177

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

9.5

355

2518

M02AA07

ATC

piroxicam; topical

1.3

9.5

1086

9125

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

9.4

265

1773

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.7

9.4

189

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

9.4

330

2311

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

9.4

109

572

N76.0

ICD-10 Finland

Acute vaginitis

1.6

9.4

203

1277

N04BC05

ATC

pramipexole; oral

1.6

9.4

224

1444

QAA30

NOMESCO Finland

Electrocoagulation of skin of head or neck

30.1

9.4

SPAT1254

SPAT

Administration of medicine

1.4

9.4

383

2761

SPAT1240

SPAT

Therapeutic discussion

1.5

9.4

311

2155

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.4

372

2669

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

9.4

243

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

9.3

328

2299

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

9.3

181

1109

C08CA01

ATC

amlodipine; oral

1.3

9.3

1073

9018

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

9.3

415

3041

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

9.3

271

1829

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.3

9.3

319

D19

ICPC

Teeth/gum symptom/complaint

1.3

9.2

868

7110

K90.0

ICD-10 Finland

Coeliac disease

2.0

9.2

465

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

9.2

753

6054

S91

ICPC

Psoriasis

3.4

9.2

R50.9

ICD-10 Finland

Fever, unspecified

1.4

9.2

415

3048

C02AC05

ATC

moxonidine; oral

1.8

9.1

125

693

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

9.1

258

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

7.7

9.1

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.3

9.1

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

9.1

122

672

P06

ICPC

Sleep disturbance

1.4

9.1

351

2505

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

9.1

1765

15729

C05AA08

ATC

fluocortolone; rectal, topical

1.4

9.1

399

2916

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.8

9.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

9.0

197

1243

N02BF01

ATC

gabapentin; oral

1.5

9.0

248

1652

L70.1

ICD-10 Finland

Acne conglobata

36.8

9.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

9.0

120

660

SAA04

NOMESCO Finland

Special examination of mouth

1.7

9.0

150

882

M79.7

ICD-10 Finland

Fibromyalgia

1.8

9.0

122

675

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

9.0

1670

14803

S01AD03

ATC

aciclovir; ophthalmic

1.9

9.0

108

575

ZXC20

NOMESCO Finland

Use of chemical agents

2.4

9.0

242

L30.4

ICD-10 Finland

Erythema intertrigo

2.6

8.9

183

WZC30

NOMESCO Finland

Teaching

1.4

8.9

465

3497

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

8.9

828

6773

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

4.3

8.9

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.8

8.9

161

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.9

8.8

139

XQ801

NOMESCO Finland

Intracutantest

3.6

8.8

SFA00

NOMESCO Finland

Small restoration

1.4

8.8

427

3172

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.1

8.8

392

S01GX09

ATC

olopatadine; ophthalmic

2.0

8.8

460

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

8.8

114

622

SPAT1360

SPAT

Extensive global examination

1.6

8.8

192

1213

H10

ICD-10 Finland

Conjunctivitis

1.6

8.8

221

1444

L28.1

ICD-10 Finland

Prurigo nodularis

3.4

8.8

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

8.7

433

3228

J46

ICD-10 Finland

Status asthmaticus

2.0

8.7

454

ZX120

NOMESCO Finland

Intravenous

1.5

8.7

265

1803

B35.1

ICD-10 Finland

Tinea unguium

1.6

8.7

183

1144

A05AA02

ATC

ursodeoxycholic acid; oral

2.4

8.7

245

H29

ICPC

Ear symptom/complaint other

1.5

8.7

323

2288

J01MA14

ATC

moxifloxacin; systemic

1.5

8.7

251

1690

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

8.7

180

1122

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.1

8.6

368

L04AA13

ATC

[U] leflunomide

2.1

8.6

402

ZX108

NOMESCO Finland

Inhalation

3.7

8.6

F72

ICPC

Blepharitis/stye/chalazion

2.2

8.6

336

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

8.6

301

2109

A11CC03

ATC

alfacalcidol; systemic

2.3

8.6

291

M45

ICD-10 Finland

Ankylosing spondylitis

2.3

8.6

291

A05

ICPC

Feeling ill

1.7

8.5

159

964

R09

ICPC

Sinus symptom/complaint

1.5

8.5

264

1804

K03.00

ICD-10 Finland

Approximal wear

1.6

8.5

205

1327

L30

ICD-10 Finland

Other dermatitis

2.1

8.4

345

A02BC04

ATC

rabeprazole; oral

1.5

8.4

276

1908

AA1AD

NOMESCO Finland

CT of head and brain

1.3

8.4

753

6121

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.4

357

2592

L40.4

ICD-10 Finland

Guttate psoriasis

4.3

8.4

S02

ICPC

Pruritus

1.9

8.4

524

A12AA04

ATC

calcium carbonate; oral

2.7

8.4

166

L01XX35

ATC

anagrelide; oral

12.8

8.4

L04AC05

ATC

ustekinumab; parenteral

4.7

8.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

8.3

328

2351

B02.9

ICD-10 Finland

Zoster without complication

1.6

8.3

186

1184

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.1

8.2

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.5

8.2

R01AD05

ATC

budesonide; nasal

1.5

8.2

234

1573

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

8.2

257

1762

L14

ICPC

Leg/thigh symptom/complaint

1.5

8.2

222

1476

R19.4

ICD-10 Finland

Change in bowel habit

2.0

8.2

438

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.2

397

2951

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

8.2

321

2299

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

8.2

350

F13

ICPC

Eye sensation abnormal

2.0

8.1

432

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

8.1

268

1856

D01AC02

ATC

miconazole; topical

1.6

8.1

204

1334

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

8.1

226

1512

JG1JB

NOMESCO Finland

Defekography with X-ray

3.2

8.1

L28

ICPC

Limited function/disability (L)

1.4

8.1

471

3605

S82

ICPC

Naevus/mole

1.4

8.0

393

2923

G03DB01

ATC

dydrogesterone; oral

1.4

8.0

425

3202

K51.5

ICD-10 Finland

Left sided colitis

2.0

8.0

413

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

10.0

8.0

K08.80

ICD-10 Finland

Toothache NOS

1.5

8.0

270

1877

K07

ICPC

Swollen ankles/oedema

1.8

8.0

119

678

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

8.0

350

2555

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

3.1

7.9

G01AF05

ATC

econazole; vaginal

1.5

7.9

265

1839

L72.0

ICD-10 Finland

Epidermal cyst

3.2

7.9

N05CF01

ATC

zopiclone; oral

1.3

7.9

945

7948

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

7.9

229

1543

M01AH01

ATC

celecoxib; oral

1.3

7.9

525

4095

T78.3

ICD-10 Finland

Angioneurotic oedema

2.5

7.9

189

S01KA02

ATC

hypromellose; ophthalmic

2.3

7.8

251

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

3.1

7.8

105

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

7.8

176

1120

R03AC13

ATC

formoterol; inhalant

1.7

7.8

148

902

SPAT1053

SPAT

Memory test

1.4

7.8

328

2376

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

7.8

133

788

N06AA09

ATC

amitriptyline; systemic

1.5

7.8

276

1937

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.5

7.8

190

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.8

723

5898

H01

ICPC

Ear pain/earache

1.4

7.8

327

2370

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.8

222

1492

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

7.8

247

1698

D86.3

ICD-10 Finland

Sarcoidosis of skin

7.0

7.8

N05CF02

ATC

zolpidem; oral

1.3

7.7

539

4235

A07EA02

ATC

hydrocortisone; rectal

2.2

7.7

305

H02.1

ICD-10 Finland

Ectropion of eyelid

3.5

7.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

3.5

7.7

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

7.7

370

2746

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

7.4

7.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

7.4

7.7

L04AA32

ATC

apremilast; oral

7.4

7.7

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

7.6

319

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

7.6

152

939

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.6

153

947

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

7.6

450

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

7.6

240

1649

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

7.6

394

2961

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.1

7.5

314

R03BC03

ATC

nedocromil; inhalant

1.5

7.5

200

1323

C08CA13

ATC

lercanidipine; oral

1.4

7.5

378

2823

S76

ICPC

Skin infection other

1.7

7.5

142

865

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

4.1

7.5

ZQZ00

NOMESCO Finland

Treatment of several skin areas

4.1

7.5

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

7.5

560

4437

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

7.5

487

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

7.5

117

677

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

7.5

179

1157

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

7.5

105

589

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.0

7.5

103

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

3.0

7.5

103

M02AA10

ATC

ketoprofen; topical

1.3

7.4

465

3593

L18

ICPC

Muscle pain

1.8

7.4

116

671

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.4

857

7172

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

7.4

144

884

L13.0

ICD-10 Finland

Dermatitis herpetiformis

4.4

7.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

7.4

136

823

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.4

432

3304

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

7.4

310

ZXA00

NOMESCO Finland

Right side

1.3

7.4

742

6109

EB1VA, ,

NOMESCO Finland

1.4

7.4

368

2746

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

7.4

211

1420

S01BA01

ATC

dexamethasone; ophthalmic

1.8

7.3

102

570

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

7.3

534

UDM02

NOMESCO Finland

Sinoscopy

2.1

7.3

318

L50.0

ICD-10 Finland

Allergic urticaria

1.9

7.3

421

D01AA02

ATC

natamycin; topical

2.1

7.3

292

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

7.3

1120

9670

L43.3

ICD-10 Finland

Subacute (active) lichen planus

6.8

7.3

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

9.4

7.3

SPAT1097

SPAT

Recording of ECG

1.4

7.3

387

2918

Z00.8

ICD-10 Finland

Other general examinations

1.5

7.3

206

1383

R07.0

ICD-10 Finland

Pain in throat

1.5

7.2

198

1319

D01

ICPC

Abdominal pain/cramps general

1.4

7.2

337

2487

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

7.2

139

852

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

7.2

515

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.9

7.2

458

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

7.2

233

1608

B35.3

ICD-10 Finland

Tinea pedis

1.7

7.2

124

738

M35.1

ICD-10 Finland

Other overlap syndromes

3.7

7.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

7.2

133

S96

ICPC

Acne

3.6

7.1

R04

ICPC

Breathing problem other

1.8

7.1

103

583

A92

ICPC

Allergy/allergic reaction NOS

1.9

7.1

446

L23

ICD-10 Finland

Allergic contact dermatitis

3.2

7.1

EMAK, ,

NOMESCO Finland

1.8

7.1

105

599

ZXA10

NOMESCO Finland

Bilateral

1.3

7.1

508

4004

M01AH02

ATC

rofecoxib; oral

1.4

7.1

346

2574

D06BB03

ATC

aciclovir; topical

1.6

7.1

139

857

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.3

7.0

225

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

7.0

144

897

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

7.0

238

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

7.0

388

2944

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

7.0

185

1224

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.0

211

1436

TK800

NOMESCO Finland

Hemodialysis

2.3

7.0

232

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

7.0

154

977

G04CA02

ATC

tamsulosin; oral

1.3

7.0

468

3653

N01

ICPC

Headache

1.4

7.0

304

2218

L04

ICPC

Chest symptom/complaint

1.6

7.0

176

1153

N05BA01

ATC

diazepam; systemic, rectal

1.4

7.0

362

2720

K51.8

ICD-10 Finland

Other ulcerative colitis

2.4

6.9

195

M19.8

ICD-10 Finland

Other specified arthrosis

1.7

6.9

116

685

A08

ICPC

Swelling

1.6

6.9

137

846

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

5.8

6.9

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

6.9

292

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

6.9

289

2094

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.9

523

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

6.9

134

824

E000008, ,

ATC

7.5

6.9

D75.2

ICD-10 Finland

Essential thrombocytosis

3.6

6.9

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.3

6.8

S01GX04

ATC

nedocromil; ophthalmic

2.2

6.8

267

L29.2

ICD-10 Finland

Pruritus vulvae

2.2

6.8

241

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

6.8

107

621

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

3.8

6.8

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.8

6.8

R06AX18

ATC

acrivastine; oral

1.9

6.8

475

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.6

6.8

149

XCK00

NOMESCO Finland

Perimetry

1.6

6.7

163

1058

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

6.7

191

1284

E000004, ,

ATC

2.1

6.7

302

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

6.7

191

1285

H60.8

ICD-10 Finland

Other otitis externa

1.8

6.7

477

D11AX14

ATC

[U] tacrolimus

3.4

6.7

S06.0

ICD-10 Finland

Concussion

1.4

6.7

284

2063

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.8

6.7

499

D10AD01

ATC

tretinoin; topical

2.0

6.7

323

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.7

341

2555

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.3

6.6

193

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.6

756

6309

L27.2

ICD-10 Finland

Dermatitis due to ingested food

3.7

6.6

QBA10

NOMESCO Finland

Incision of skin of trunk

2.8

6.6

116

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

2.6

6.6

139

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.0

6.6

C07AG02

ATC

carvedilol; oral

1.6

6.6

141

888

C09CA01

ATC

losartan; oral

1.3

6.6

698

5777

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.0

6.6

318

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

6.6

152

976

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

6.6

187

1258

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.2

6.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

6.6

237

1672

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

6.5

345

2598

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.8

6.5

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

6.5

319

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

6.5

220

A06AD11

ATC

lactulose; oral

1.4

6.5

356

2696

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.3

6.5

214

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.3

6.5

189

R29

ICPC

Respiratory symptom/complaint other

1.5

6.5

190

1287

UDC00

NOMESCO Finland

Ear microscopy

1.5

6.4

196

1337

R49.01

ICD-10 Finland

Functional dysphonia

1.8

6.4

542

X86

ICPC

Abnormal cervix smear

2.7

6.4

118

L66.9

ICD-10 Finland

Cicatricial alopecia, unspecified

70.0

6.4

H92.0

ICD-10 Finland

Otalgia

1.5

6.4

173

1150

S19

ICPC

Skin injury other

1.8

6.4

572

UJD02

NOMESCO Finland

Gastroscopy

1.6

6.4

124

762

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

6.4

262

1891

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.7

6.4

124

C08CA05

ATC

nifedipine; systemic

1.6

6.4

145

927

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

6.4

224

1572

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.4

520

4167

ZZR00

NOMESCO Finland

Flap of skin

2.1

6.4

268

L04AC10

ATC

secukinumab; parenteral

3.7

6.4

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

6.3

105

619

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

4.1

6.3

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.0

6.3

357

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

6.3

242

N17

ICPC

Vertigo/dizziness

1.4

6.3

329

2471

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

6.3

282

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.9

6.3

421

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.3

163

1074

M34.1

ICD-10 Finland

CR(E)ST syndrome

3.6

6.3

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.8

6.3

553

D06BB04

ATC

podophyllotoxin; topical

1.6

6.3

140

891

ZQX00

NOMESCO Finland

0-4% of the skin

9.3

6.3

L01BB02

ATC

mercaptopurine; oral

2.6

6.3

137

EB4VA, ,

NOMESCO Finland

1.4

6.3

320

2397

K58

ICD-10 Finland

Irritable bowel syndrome

1.9

6.3

401

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

6.2

269

1959

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

6.2

181

1223

L86

ICPC

Back syndrome with radiating pain

1.5

6.2

169

1126

L08.0

ICD-10 Finland

Pyoderma

2.9

6.2

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.7

6.2

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

6.2

497

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.1

630

5191

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

6.1

236

1686

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.1

218

1535

R5110, ,

SPAT

1.5

6.1

171

1147

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

6.1

111

672

M54.2

ICD-10 Finland

Cervicalgia

1.4

6.1

235

1679

A03FA02

ATC

cisapride; oral, rectal

1.5

6.1

192

1320

D09AB01

ATC

zinc bandage without supplements; topical

2.1

6.1

253

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

6.1

252

1825

N03AE01

ATC

clonazepam; systemic

1.5

6.0

158

1044

S12

ICPC

Insect bite/sting

1.4

6.0

225

1597

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.7

6.0

D11AH05

ATC

dupilumab; topical

6.7

6.0

N05BA04

ATC

oxazepam; oral

1.2

6.0

758

6389

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

6.0

146

949

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

952

4260

2.68

133.99

1.6

1.3

622.69

585.70

titre

0.20

245

926

(40768443) Skin Pathology biopsy report

415

1250

3.62

115.53

1.4

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

392

1247

3.41

99.78

1.4

1.3

1.54

1.36

u/ml

0.09

105

(40760892) CBC W Ordered Manual Differential panel - Blood

2049

14093

2.06

94.29

9.0

6.2

—

(3006315) Basophils [#/volume] in Blood

2139

15011

2.05

92.25

8.2

5.7

0.04

e9/l

0.13

1948

12970

(3001604) Monocytes [#/volume] in Blood

2134

14979

2.05

91.78

8.2

5.7

0.54

0.56

e9/l

3.66

1946

12966

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

323

961

3.59

90.96

2.1

1.8

—

(3013115) Eosinophils [#/volume] in Blood

2186

15566

2.03

89.20

8.4

5.9

0.18

0.19

e9/l

0.85

2003

13683

(3019198) Lymphocytes [#/volume] in Blood

2167

15423

2.02

88.04

8.2

5.8

1.85

1.93

e9/l

1.89

1992

13673

(3013707) Erythrocyte sedimentation rate by Westergren method

2854

22577

2.28

86.35

5.7

4.0

11.73

11.75

mm/h

0.03

2698

20989

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

314

952

3.52

85.80

2.2

1.7

1.16

1.18

g/l

0.42

299

901

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

302

915

3.51

82.53

2.3

1.8

0.22

0.23

g/l

1.47

283

864

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

289

912

3.36

73.91

1.4

1.2

31.03

40.01

u/ml

0.26

(3005322) IgE [Units/volume] in Serum or Plasma

474

1977

2.61

73.18

1.3

195.07

189.14

u/ml

0.06

454

1832

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

231

653

3.71

69.88

1.4

1.2

4.31

3.28

u/ml

0.15

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2836

23046

2.09

69.81

9.4

7.4

76.67

76.88

u/l

0.09

2702

21755

(3013650) Neutrophils [#/volume] in Blood by Automated count

2299

17422

1.89

69.33

10.7

8.9

3.91

4.02

e9/l

1.70

2109

15204

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

261

828

3.32

66.05

1.5

1.3

11.68

6.71

u/ml

0.33

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

263

841

3.30

65.70

1.5

1.3

10.09

8.87

u/ml

0.09

144

(3006504) Eosinophils/100 leukocytes in Blood

1920

14039

1.79

61.97

8.5

5.9

2.80

2.84

0.45

1831

13107

(3019069) Monocytes/100 leukocytes in Blood

1927

14126

1.79

61.46

8.9

6.2

8.40

8.44

0.26

1843

13215

(3007853) Bacteria identified in Skin by Aerobe culture

644

3349

2.12

58.90

1.9

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

1936

14328

1.76

58.62

8.2

5.8

57.31

56.92

0.82

1850

13421

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

943

5625

1.92

58.55

1.4

1.3

38.92

29.74

iu/ml

0.80

286

1848

(3002030) Lymphocytes/100 leukocytes in Blood

1953

14524

1.75

57.81

8.7

6.0

28.27

28.36

0.13

1868

13623

(3022096) Basophils/100 leukocytes in Blood

1854

13592

1.75

57.67

8.6

5.9

0.72

0.69

1.67

1762

12655

(3048689) Calprotectin [Mass/mass] in Stool

686

3735

2.03

55.11

2.8

2.3

114.53

124.99

ug/g

0.38

542

2966

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1739

12692

1.72

53.47

2.7

2.2

76.92

77.40

nmol/l

0.30

1617

11516

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1078

6940

1.79

51.23

1.4

1.3

1.63

1.68

u/ml

0.05

300

1928

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

207

692

3.11

47.83

1.4

1.2

48.13

42.46

u/ml

0.20

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

871

5405

1.81

46.03

1.4

1.3

7.35

10.54

u/ml

0.93

343

2154

(3029937) Albumin [Presence] in Urine by Test strip

1162

7844

1.71

45.65

5.1

3.9

0.00

estimate

1.49

383

2693

(3007164) IgA [Mass/volume] in Serum or Plasma

943

6022

1.77

45.06

1.6

1.4

2.56

2.37

g/l

1.76

611

3735

(3037467) Urinalysis macro (dipstick) panel - Urine

2503

20653

1.70

44.51

5.4

4.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1131

7631

1.70

44.21

3.1

2.5

3410.16

4652.13

umol/l

0.59

985

6745

(3039162) Centromere protein B Ab [Units/volume] in Serum

141

393

3.69

43.42

1.4

1.3

66.76

50.78

u/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1867

14405

1.62

42.39

7.6

6.5

1.22

mmol/l

0.09

1621

12260

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3339

30357

2.41

41.23

17.1

13.2

19.38

22.37

mg/l

6.05

2753

23870

(3021601) Nitrite [Presence] in Urine by Test strip

1894

14742

1.60

40.84

5.9

4.8

0.00

estimate

0.80

401

2759

(3009261) Glucose [Presence] in Urine by Test strip

1906

14899

1.59

40.04

4.7

3.6

0.01

0.00

estimate

0.14

377

2698

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2809

24174

1.74

39.99

5.0

4.1

14.78

14.67

pmol/l

1.62

2599

22233

(3035350) Ketones [Presence] in Urine by Test strip

1887

14737

1.59

39.62

4.6

3.6

0.00

estimate

1.47

408

2912

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1710

13075

1.59

39.13

6.6

5.7

1.21

mmol/l

0.12

1581

11952

(3000494) Fungus identified in Specimen by Culture

604

3519

1.86

38.42

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

433

2267

2.03

37.76

3.1

2.8

10.90

10.56

g/l

0.83

401

2078

(3015736) pH of Urine

1565

11861

1.57

36.26

4.2

3.3

5.90

5.85

0.20

105

966

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1930

15375

1.55

35.48

6.3

6.1

11.11

10.92

umol/l

0.27

1826

14613

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3153

28387

1.90

34.71

5.9

4.9

1.90

2.08

mu/l

0.99

2954

26279

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1262

9201

1.57

34.08

3.0

2.5

56.94

67.43

u/l

0.63

1162

8512

(3024561) Albumin [Mass/volume] in Serum or Plasma

1622

12512

1.54

33.97

6.0

4.7

36.10

35.78

g/l

1.65

1512

11677

(3031040) Bacteria [#/volume] in Urine by Automated count

2359

19760

1.56

33.79

5.1

4.3

1958.11

1949.60

e6/l

0.00

259

(3004616) Nuclear Ab [Presence] in Serum

124

380

3.34

33.05

1.5

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1484

11323

1.53

32.10

4.8

3.7

—

(40768804) Tissue Pathology biopsy report

1646

12852

1.52

31.87

2.4

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

342

1762

2.04

30.94

1.8

1.22

1.40

g/l

0.69

313

1617

(3021589) Normoblasts [#/volume] in Blood

1692

13343

1.51

30.90

11.9

9.1

0.00

e9/l

0.66

1463

10863

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3448

32376

2.60

29.60

14.4

10.0

25.88

25.61

u/l

0.43

3368

31342

(3025159) Blasts/100 leukocytes in Blood

404

2250

1.90

29.09

5.4

4.2

0.22

0.37

0.32

103

586

(3021440) Promyelocytes/100 leukocytes in Blood

416

2352

1.87

28.56

5.4

4.2

0.12

0.11

0.10

113

688

(3017181) Myelocytes/100 leukocytes in Blood

430

2468

1.84

28.12

5.4

4.1

0.92

0.01

126

804

(3022948) Iron [Moles/volume] in Serum or Plasma

683

4466

1.65

28.12

2.8

2.4

13.58

13.51

umol/l

0.10

640

4177

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1011

7272

1.54

27.75

2.5

2.2

3.07

2.92

mg/l

0.81

895

6233

(3019150) Specific gravity of Urine by Refractometry

901

6317

1.57

27.73

5.2

3.9

1.02

kg/l

1.00

118

919

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

264

1288

2.13

27.55

2.0

1.9

40.37

39.68

u/l

0.21

238

1159

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1509

11812

1.48

27.47

2.1

1.9

98.59

96.68

pmol/l

0.74

801

6016

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3207

29445

1.83

27.36

5.0

4.4

5.85

5.86

mmol/l

0.14

2999

27115

(3022145) Colonoscopy Study observation

533

3290

1.73

27.17

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

399

2261

1.86

27.14

5.2

3.9

0.69

0.68

0.02

117

702

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

239

3.66

26.66

1.3

1.2

66.83

34.46

u/ml

0.60

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1169

8745

1.50

26.39

2.4

2.1

151.49

207.93

u/l

2.06

1089

8238

(3018418) pH of Serum or Plasma

1150

8598

1.50

25.94

4.9

3.9

7.39

7.40

1.30

214

1652

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1690

13632

1.45

25.76

3.4

2.8

125.50

111.56

ug/l

0.80

1593

12712

(3019309) Folate [Moles/volume] in Red Blood Cells

748

5106

1.59

25.55

1.8

1.7

1190.71

1176.93

nmol/l

0.16

578

3902

(40761535) Cells panel - Urine sediment

405

2363

1.80

24.97

4.6

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

466

2847

1.73

24.49

2.3

2.1

355.24

369.37

nmol/l

0.59

423

2621

(3009445) Proteinase 3 Ab [Units/volume] in Serum

241

1188

2.10

24.45

2.0

1.5

22.53

16.73

u/ml

0.18

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

181

796

2.34

24.29

2.1

2.0

11.13

11.49

mg/l

0.20

172

733

(40761511) CBC panel - Blood by Automated count

3383

31795

2.09

24.19

15.9

12.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1370

10724

1.45

23.94

3.7

3.4

72.05

98.11

ng/l

0.16

886

6828

(3019550) Sodium [Moles/volume] in Serum or Plasma

3319

31005

1.92

23.92

18.4

14.7

139.52

139.69

mmol/l

3.66

3248

30232

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

228

3.57

23.92

1.3

1.2

11.44

7.74

u/ml

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3324

31102

1.92

23.31

18.6

14.8

3.95

mmol/l

0.17

3249

30272

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3030

27645

1.61

23.28

6.1

5.4

38.76

39.29

mmol/mol

3.19

2842

25720

(3023420) DNA double strand Ab [Units/volume] in Serum

101

340

3.03

23.09

2.4

1.5

28.73

25.24

iu/ml

0.14

(3017143) Hepatitis C virus Ab [Presence] in Serum

531

3410

1.65

23.07

1.8

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

944

6929

1.49

22.72

5.0

3.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

611

4085

1.60

22.50

2.9

2.4

2.37

2.35

g/l

0.26

571

3795

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3247

30216

1.77

22.46

5.2

4.2

4.70

4.76

mmol/l

3.32

3081

28260

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

194

916

2.18

21.97

1.7

1.6

1.37

7.08

iu/ml

0.39

178

(4200892) Spirometry reversibility

355

2073

1.79

21.72

1.6

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

572

3796

1.60

21.66

3.0

2.5

23.62

23.33

0.19

479

3258

(3013826) Glucose [Moles/volume] in Serum or Plasma

2007

17043

1.40

21.17

5.4

4.5

6.53

6.62

mmol/l

1.28

1897

15897

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

197

950

2.14

21.15

1.8

1.7

342.50

348.70

titre

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3279

30702

1.78

20.81

5.4

4.7

2.78

2.83

mmol/l

2.04

3085

28548

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

133

4.18

20.73

1.1

—

(3044889) 12 lead EKG panel

2391

20994

1.41

20.33

4.2

3.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

850

6238

1.47

20.08

1.7

1.6

47978126.80

32568717.51

pmol/l

0.23

717

5272

(36660697) Celiac disease serology panel - Serum

397

2452

1.70

19.86

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3516

33815

2.83

19.80

25.9

19.5

40.26

40.03

1.53

3303

31833

(3000963) Hemoglobin [Mass/volume] in Blood

3520

33877

2.90

19.72

26.0

19.5

134.93

134.68

g/l

0.52

3489

33433

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

471

3051

1.63

19.57

4.5

4.3

249.14

247.47

u/l

0.08

445

2880

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1261

9987

1.40

19.55

3.8

3.2

32.08

34.23

u/l

0.52

1193

9520

(3021960) Folate [Moles/volume] in Serum or Plasma

883

6559

1.46

19.52

1.5

20.41

20.81

nmol/l

0.30

775

5640

(3010813) Leukocytes [#/volume] in Blood

3518

33863

2.84

19.41

25.9

19.4

6.63

6.64

e9/l

0.12

3462

32981

(3024731) MCV [Entitic volume]

3518

33863

2.84

19.41

25.8

19.4

91.33

90.93

5.68

3486

33424

(3007461) Platelets [#/volume] in Blood

3517

33850

2.82

19.39

25.9

19.4

256.98

256.55

e9/l

0.14

3468

33053

(3035941) MCH [Entitic mass]

3518

33865

2.84

19.37

25.7

19.3

30.38

30.26

3.63

3487

33423

(3026361) Erythrocytes [#/volume] in Blood

3518

33869

2.83

19.29

25.9

19.4

4.47

4.48

e12/l

0.37

3460

32987

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3214

30039

1.66

19.11

4.9

4.2

1.49

1.51

mmol/l

1.66

3021

27948

(3025941) Bacteria identified in Stool by Culture

306

1783

1.78

18.80

1.4

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

821

6057

1.46

18.68

3.1

2.5

6.52

6.28

e6/l

0.09

754

5430

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

989

7554

1.43

18.67

3.1

2.9

1204.08

1181.78

ng/l

0.05

832

6417

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3115

28968

1.57

18.06

4.7

3.8

1.30

1.28

mmol/l

1.10

2927

26754

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

134

591

2.32

17.91

4.5

3.6

54.49

57.14

1.55

134

591

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

279

2.95

17.86

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1283

10317

1.38

17.70

4.5

3.5

97.22

98.14

e6/l

0.01

948

7186

(3022217) INR in Platelet poor plasma by Coagulation assay

1558

12925

1.36

17.66

15.2

13.7

1.23

1.22

inr

0.13

499

3820

(3002385) Erythrocyte distribution width [Ratio]

2880

26389

1.46

17.58

19.9

15.7

14.98

14.81

0.79

2843

25930

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

334

2043

1.70

17.25

2.0

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1032

8040

1.40

17.11

1.9

1.6

1.38

1.37

mmol/l

0.08

877

6805

(40758558) Short blood count panel - Blood

986

7647

1.40

16.71

8.2

6.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

526

3619

1.53

16.69

7.6

5.6

1.04

mmol/l

0.14

499

3365

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2314

20505

1.36

16.59

3.7

3.0

53.05

45.29

u/l

2.06

2153

19222

(3015377) Calcium [Moles/volume] in Serum or Plasma

1251

10097

1.37

16.59

3.4

3.3

2.35

mmol/l

1.38

1108

8971

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

123

541

2.32

16.57

1.3

—

271.67

—

(3004588) Protein electrophoresis panel - Serum or Plasma

306

1849

1.72

16.52

2.3

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

773

5761

1.44

16.38

1.6

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

356

2251

1.65

16.18

2.3

2.7

67.33

66.68

g/l

0.94

326

2061

(40768797) Stomach Pathology biopsy report

601

4282

1.48

16.08

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

100

413

2.46

15.52

1.3

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

877

6749

1.40

15.35

1.8

1.7

0.94

1.10

mg/l

1.44

655

5146

(3008898) HLA-B27 [Presence]

207

1140

1.87

15.28

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

122

557

2.23

15.08

8.6

5.1

265.35

602.94

iu/ml

0.70

(3013139) Helicobacter pylori Ag [Presence] in Stool

335

2132

1.63

14.81

1.2

—

(3042936) Bacteria identified in Isolate by Culture

562

4030

1.47

14.43

2.1

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

110

494

2.27

14.16

1.3

1.6

0.64

0.75

g/l

0.55

370

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3065

28717

1.46

13.94

15.2

12.1

82.34

82.58

ml/min/173m2

0.24

2585

23772

(3020961) Endomysium IgA Ab [Titer] in Serum

250

1500

1.72

13.83

1.2

1.1

20.71

162.07

titre

—

(3023520) Reticulocytes [#/volume] in Blood

336

2185

1.59

13.57

2.7

2.6

70.53

70.43

e9/l

0.02

245

1657

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

4.05

13.53

3.2

3.0

8.24

7.24

mg/l

0.46

(3041096) Erythrocytes [Presence] in Urine by Automated

1000

7997

1.35

13.45

3.8

3.2

—

(3030467) Casts [#/volume] in Urine by Automated count

999

7991

1.35

13.41

3.8

3.0

0.33

0.39

e6/l

0.42

794

6041

(36304419) Bacteria [Presence] in Urine

981

7833

1.35

13.31

3.7

2.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

117

3.62

13.12

1.3

1.2

0.28

0.29

g/l

0.29

(3027945) Reticulocytes/100 erythrocytes in Blood

431

2985

1.50

13.09

2.8

2.5

1.79

1.78

0.03

395

2646

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

332

2172

1.58

13.06

4.6

3.6

90.69

86.04

ng/l

0.41

292

1887

(3003327) Ova and parasites identified in Stool by Light microscopy

180

1001

1.84

12.91

1.8

1.7

—

(44813793) Dust mix specific IgE antibody measurement

226

2.77

12.43

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

116

565

2.09

12.24

1.6

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

154

830

1.89

12.20

1.2

946.67

1089.31

titre

—

(3002582) Erythrocytes [#/volume] in Urine

1065

8695

1.32

12.19

3.9

3.1

32.68

100.56

e6/l

3.01

848

6627

(3012095) Magnesium [Moles/volume] in Serum or Plasma

615

4613

1.40

12.19

3.7

3.3

0.81

0.82

mmol/l

0.91

566

4338

(3010375) cycloSPORINE [Mass/volume] in Blood

114

3.54

12.10

19.1

26.1

109.39

114.01

ug/l

0.15

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

102

475

2.18

12.08

1.7

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

198

1158

1.75

12.01

2.8

2.0

4320.01

5528.39

u/l

0.22

475

(3020779) Urea [Moles/volume] in Serum or Plasma

348

2348

1.53

11.93

10.2

7.3

9.90

9.31

mmol/l

0.80

333

2240

(46235355) HIV 1 and 2 tests - Meaningful Use set

701

5395

1.37

11.87

1.9

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

345

2333

1.53

11.70

1.2

85.64

151.32

iu/ml

4.89

159

899

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

385

2.29

11.66

1.1

1.53

1.51

g/l

0.13

346

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

184

2.91

11.64

1.6

1.4

19.73

22.15

u/ml

0.12

(3007566) Smooth muscle Ab [Titer] in Serum

151

822

1.87

11.61

1.2

56.15

101.88

titre

2.37

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.91

11.54

3.0

2.4

131.66

162.03

au/ml

—

(3013293) Extractable nuclear Ab [Presence] in Serum

5.25

11.53

1.8

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

105

505

2.11

11.47

1.6

1.4

110.60

123.93

u/ml

0.53

(4062490) Immunoglobulin typing, IgG

316

2.40

11.24

1.2

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

179

2.88

11.00

1.6

1.7

4.86

5.92

u/l

1.33

156

(3017446) Testosterone [Moles/volume] in Serum or Plasma

241

1536

1.61

10.58

2.4

2.1

11.77

12.22

nmol/l

0.36

218

1366

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

485

3581

1.41

10.43

8.0

6.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

316

2.34

10.33

1.3

1.4

0.41

g/l

0.03

220

(3028192) IgG subclass 2 [Mass/volume] in Serum

316

2.34

10.33

1.3

1.4

3.22

2.89

g/l

0.70

220

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

133

723

1.87

10.31

1.6

1.4

8.74

18.54

iu/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

112

576

1.97

10.24

1.6

1.3

—

19.29

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

324

2227

1.50

10.16

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

1078

8989

1.28

10.15

3.3

3.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.62

10.07

2.0

8.46

9.94

mg/l

0.73

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.97

10.03

1.9

1.7

58.15

45.27

au/ml

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

317

2.30

9.82

1.3

1.4

6.41

6.92

g/l

0.55

221

(3012516) Albumin [Mass/volume] in Urine

989

8224

1.28

9.38

3.5

3.2

834.95

347.61

mg/l

1.47

614

5125

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2217

20220

1.25

9.37

3.2

3.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

151

880

1.75

9.34

1.4

317.65

292.38

ug/g

0.71

489

(3042733) HLA Ab [Presence] in Serum

3.75

9.32

7.4

5.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

339

2395

1.46

9.26

2.8

2.5

64.82

68.19

ml/min/173m2

0.92

155

909

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

129

720

1.82

9.23

3.4

3.2

1.55

1.51

mg/l

0.17

119

663

(3013637) Mi-2 Ab [Presence] in Serum

3.82

9.22

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.82

9.22

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.82

9.22

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.82

9.22

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

121

3.08

9.08

1.3

1.1

—

(3002256) Pathology report gross observation

518

3953

1.36

9.07

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

476

2.00

9.02

1.1

1.10

1.60

u/ml

0.64

208

(3018677) aPTT in Platelet poor plasma by Coagulation assay

555

4286

1.35

8.99

2.1

29.74

29.63

0.15

532

4154

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

585

4556

1.34

8.95

1.7

1.6

—

(3026782) Osmolality of Urine

714

5737

1.31

8.74

3.6

2.8

525.13

535.07

mosm/kgh2o

0.59

617

4942

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

151

897

1.71

8.74

1.3

1.2

—

(3023368) Bacteria identified in Blood by Culture

893

7386

1.28

8.74

4.3

4.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

609

1.87

8.73

1.2

1.1

1.54

2.50

u/ml

0.66

294

(3009508) Creatinine [Moles/volume] in Urine

1045

8817

1.26

8.66

3.5

3.1

7.25

7.43

mmol/l

0.65

901

7475

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

397

2922

1.40

8.65

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

312

2198

1.46

8.65

2.4

11.26

22.40

au/ml

3.16

180

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

164

2.70

8.56

2.7

37.34

43.39

1.15

(3014765) Yersinia sp identified in Stool by Organism specific culture

151

904

1.70

8.51

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

152

913

1.69

8.46

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

287

2001

1.47

8.39

1.3

35.54

49.99

au/ml

—

120

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

146

870

1.71

8.37

1.1

13.95

5.47

u/ml

0.37

111

(3020682) Albumin/Creatinine [Ratio] in Urine

1024

8648

1.26

8.36

4.2

3.8

13.01

8.29

mg/mmol

1.07

634

5364

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

616

4883

1.32

8.29

3.2

2.6

0.96

1.17

e6/l

0.74

384

2731

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

107

585

1.85

8.22

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

101

542

1.89

8.22

1.1

3.82

4.79

u/ml

0.31

255

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

465

3546

1.36

8.14

1.7

1.44

1.42

0.21

394

3134

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.33

8.13

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.33

8.13

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.33

8.13

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

425

2.00

8.12

4.1

2.6

1264.63

1745.60

u/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

199

2.48

8.05

2.1

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

519

1.89

7.97

1.1

1.30

1.10

u/ml

0.14

197

(40759836) Histone Ab [Presence] in Serum by Immunoblot

244

2.32

7.90

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

244

2.32

7.90

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

154

2.68

7.89

1.4

1.5

18.09

26.97

umol/l

1.43

145

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

245

2.31

7.83

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

146

887

1.67

7.81

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

356

2.07

7.81

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

544

1.84

7.52

1.2

313.87

265.73

u/ml

0.59

340

(3013512) EKG study

981

8328

1.24

7.51

3.9

3.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

566

4494

1.31

7.48

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

730

5998

1.27

7.39

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

432

3306

1.35

7.38

2.0

—

(40768446) Kidney Pathology biopsy report

3.05

7.30

1.5

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.10

7.27

1.7

1.6

8.59

8.49

ug/l

0.06

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

290

2085

1.43

7.22

3.9

3.3

4.43

4.46

pmol/l

0.22

253

1878

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

662

5401

1.28

7.07

2.9

2.44

2.45

mmol/l

0.81

576

4754

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

157

1002

1.59

6.94

1.9

2.5

2.85

2.94

g/l

0.49

147

914

(3019060) Gas panel - Arterial blood

250

1762

1.45

6.94

5.0

5.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

374

1.97

6.87

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

236

1649

1.46

6.85

1.1

1.0

—

(3011412) CD3 cells [#/volume] in Blood

274

2.14

6.79

2.4

1.22

1.20

e9/l

0.04

252

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

302

2215

1.40

6.72

3.1

2.8

162.81

180.03

ng/l

0.36

271

2008

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1066

1.56

6.72

1.9

2.4

3.76

3.64

g/l

0.39

153

979

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.51

6.71

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1067

1.56

6.69

1.9

2.4

7.22

7.37

g/l

0.62

154

978

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1067

1.56

6.69

1.9

2.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

739

1.67

6.66

1.4

1.3

8.90

12.21

u/l

2.05

100

615

(3008152) Bicarbonate [Moles/volume] in Arterial blood

242

1712

1.44

6.59

7.2

24.51

24.54

mmol/l

0.06

227

1627

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

401

3086

1.34

6.59

1.9

1.7

—

(3037121) Protein [Mass/volume] in Urine

147

939

1.59

6.50

3.8

3.1

0.23

0.29

g/l

0.56

355

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

106

624

1.72

6.44

1.6

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

438

3426

1.32

6.42

2.8

2.7

6.92

7.36

umol/l

0.27

383

2975

(3004716) Salmonella sp identified in Stool by Organism specific culture

230

1621

1.45

6.40

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

529

1.78

6.37

1.4

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

397

3067

1.33

6.35

1.8

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

4.06

6.35

1.1

1.0

0.02

2.68

u/ml

0.58

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

217

1521

1.45

6.22

2.3

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

496

1.79

6.22

1.3

1.2

4.15

4.22

u/ml

0.01

164

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

358

2734

1.34

6.19

2.5

2.2

0.22

g/l

0.07

330

2565

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

238

2.16

6.19

1.3

1.2

3.08

1.00

u/ml

0.54

126

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

187

2.32

6.17

2.5

2.6

517.37

505.59

e6/l

0.06

160

(3020876) Protein [Mass/time] in 24 hour Urine

292

2.04

6.15

2.4

2.3

1.20

1.42

g/24h

0.24

142

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

2.33

5.99

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

177

2.33

5.99

2.6

0.22

0.20

e9/l

0.16

157

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

358

1.92

5.96

1.3

1.4

327.51

324.87

pmol/l

0.03

315

(3020891) Body temperature

162

1081

1.52

5.94

4.3

4.5

—

(3000060) B lymphocytes [#/volume] in Blood

3.20

5.86

2.0

2.5

150.00

147.71

e6/l

0.02

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.35

5.83

1.0

0.01

0.29

u/ml

0.63

(3020123) Porphyrins [Interpretation] in Serum or Plasma

8.02

5.83

1.1

—

(3000492) Spirometry study

384

2989

1.32

5.83

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

404

1.85

5.82

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

238

2.12

5.79

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

149

2.43

5.78

1.1

1.0

96.15

94.18

0.13

117

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

141

921

1.55

5.70

2.3

2.5

0.69

0.90

g/l

0.30

126

812

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

480

1.77

5.70

1.3

1.2

4.94

4.98

u/ml

0.01

202

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

218

1556

1.43

5.69

1.6

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

301

2275

1.35

5.59

2.5

2.3

9.24

6.95

ug/l

0.36

260

2016

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.81

5.56

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

189

1321

1.45

5.53

1.4

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

170

1168

1.48

5.44

1.5

1.8

1.53

1.55

g/l

0.06

149

1008

(3011985) Renin [Units/volume] in Plasma

385

1.83

5.41

1.5

73.91

50.15

mu/l

0.51

347

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

148

991

1.51

5.37

2.0

2.5

10.34

10.10

g/l

0.29

137

897

(21491868) Cryoglobulin [Mass/volume] in Serum

118

2.56

5.37

1.1

1.2

—

0.16

g/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

574

1.67

5.31

2.2

1.9

5.19

5.13

mmol/24h

0.06

498

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

126

817

1.56

5.29

1.9

2.4

0.00

0.02

g/l

1.54

118

761

(3016502) Oxygen saturation in Arterial blood

354

2762

1.31

5.29

7.2

8.0

96.07

95.80

0.43

341

2669

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

227

2.08

5.28

1.3

1.2

230.00

174.29

titre

—

(3023419) Bacteria identified in Sputum by Culture

426

1.78

5.23

2.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

262

2.00

5.22

1.4

11023.78

50219.15

e6/l

0.83

180

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.59

5.17

4.6

5.8

—

(3017732) Neutrophils [#/volume] in Blood

282

2140

1.34

5.11

2.6

2.8

4.31

4.84

e9/l

0.48

236

1769

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

646

5440

1.23

5.11

4.0

3.5

236.45

380.78

ng/l

1.17

452

3970

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

170

1186

1.45

5.05

1.6

—

(3045424) Erythrocytes [Presence] in Urine

521

1.69

5.05

1.8

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

198

2.13

5.03

1.7

1.9

18.08

nmol/l

0.00

186

(3027801) Oxygen [Partial pressure] in Arterial blood

390

3107

1.29

4.99

6.8

7.5

12.02

12.65

kpa

1.84

368

2975

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

140

943

1.50

4.96

2.8

2.3

294.10

705.06

ug/l

1.09

123

875

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

100

2.61

4.88

1.2

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

389

3108

1.28

4.86

6.8

7.5

5.02

5.10

kpa

0.92

365

2976

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

104

659

1.60

4.85

1.4

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

306

2370

1.32

4.83

4.4

3.7

1.23

mmol/l

0.32

259

2075

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

270

1.94

4.82

1.3

1.5

29.71

33.71

0.31

159

(3033658) Prothrombin time (PT) actual/Normal

864

7524

1.20

4.81

4.3

3.8

92.19

92.56

0.16

828

7324

(3000475) Leukocytes [#/volume] in Synovial fluid

106

677

1.58

4.79

1.7

1.6

9499.32

12795.67

e6/l

0.35

489

(3003396) Base excess in Arterial blood by calculation

387

3104

1.28

4.69

6.9

7.5

1.00

1.08

mmol/l

0.14

286

2450

(40761536) Microorganisms panel - Urine sediment

325

2550

1.30

4.68

4.6

3.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

246

1856

1.35

4.66

1.4

1.3

26.13

31.56

iu/l

1.70

211

1606

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.13

4.60

2.5

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

130

878

1.50

4.58

2.8

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

444

1.70

4.57

4.7

3.2

1.83

1.44

0.24

398

(3019225) pH of Specimen

360

2872

1.28

4.56

4.6

4.1

—

(3052851) Hemolysis interference index of Serum or Plasma

128

863

1.50

4.55

2.8

3.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.65

4.48

1.0

1.1

0.56

1.78

u/ml

0.52

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

120

803

1.51

4.43

2.3

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

202

2.04

4.42

1.1

1.00

1.04

ratio

1.44

(3024471) HLA-A [Type]

2.69

4.41

1.0

—

(3037756) Immunofixation for Serum or Plasma

565

1.61

4.39

1.5

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

374

1.75

4.39

1.3

—

nmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

2.42

4.38

4.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.56

4.38

1.0

10.86

12.73

u/ml

0.08

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.26

4.29

2.0

2.1

1.92

3.10

mg/l

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

5.51

4.28

2.5

2.2

22.45

18.79

mg/l

0.34

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

319

1.80

4.24

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.42

4.18

1.1

0.01

0.04

u/ml

1.16

(3034274) Bile acid [Moles/volume] in Serum --fasting

343

1.76

4.17

1.6

2.1

5.91

5.47

umol/l

0.18

242

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

242

1.91

4.15

1.1

1.2

—

(3024932) HLA-DR beta [Type]

2.67

4.15

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

129

889

1.47

4.15

7.1

6.8

1.34

1.25

mmol/l

0.66

118

783

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

113

758

1.51

4.15

2.0

2.4

0.00

g/l

-0.00

105

706

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

112

751

1.51

4.12

2.0

2.4

0.00

g/l

-0.00

105

705

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

216

1.96

4.05

1.5

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

123

844

1.47

4.05

1.9

2.3

38.09

38.04

g/l

0.03

113

754

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

124

853

1.47

4.03

3.2

3.6

30.35

68.05

mg/l

1.52

696

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

121

829

1.48

4.02

3.2

3.6

1.24

1.61

ratio

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

427

3530

1.24

4.00

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

219

1669

1.33

3.92

3.8

3.5

4.96

5.16

kpa

3.87

206

1597

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

151

1084

1.41

3.92

6.1

6.0

1.71

1.62

0.58

139

1015

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

481

1.61

3.88

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

123

853

1.46

3.85

3.2

3.6

43.32

57.79

mg/l

0.82

697

(3021387) Prolactin [Units/volume] in Serum or Plasma

147

1054

1.41

3.85

1.7

1.6

261.83

306.32

mu/l

1.62

134

946

(1616796) Gas panel - Central venous blood

601

1.54

3.84

3.5

3.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

337

1.73

3.84

2.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

101

2.39

3.81

1.8

1.3

61.26

142.71

nmol/24h

0.70

101

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

126

881

1.45

3.79

1.5

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

173

2.03

3.79

1.1

1.0

0.24

0.28

u/ml

0.15

(3021447) Carbon dioxide [Partial pressure] in Venous blood

301

2406

1.27

3.79

5.7

3.6

5.80

5.81

kpa

0.11

293

2338

(3042631) Mycobacterium sp identified in Specimen

362

1.70

3.75

3.0

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

174

2.02

3.73

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.92

3.72

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

558

1.55

3.71

4.1

2.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

320

2584

1.26

3.70

7.8

8.4

122.16

121.38

g/l

0.27

311

2517

(3015235) Bicarbonate [Moles/volume] in Capillary blood

655

1.51

3.70

2.8

3.2

23.69

24.88

mmol/l

2.51

641

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

360

2948

1.25

3.69

3.2

—

(3036489) Thrombin time

152

1106

1.39

3.67

2.3

2.0

20.49

21.30

1.70

119

955

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.12

3.64

1.5

1.4

93.56

118.53

ng/l

0.40

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

497

1.58

3.64

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1532

14181

1.14

3.64

2.7

2.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

148

1074

1.39

3.63

6.2

6.0

0.92

0.91

0.05

137

1005

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

345

2818

1.25

3.62

2.6

2.3

47.49

38.69

u/l

0.36

298

2414

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

570

1.54

3.60

1.4

31.65

29.90

u/l

0.17

469

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.95

3.57

2.3

8.4

69.80

73.55

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

437

1.61

3.56

1.1

4.30

2.68

u/ml

0.40

186

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.40

3.55

1.3

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

137

2.13

3.54

1.1

4.65

6.16

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

111

2.26

3.54

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

646

1.50

3.52

3.0

3.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

392

1.64

3.52

1.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

470

1.59

3.52

1.7

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

771

1.45

3.48

1.5

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

464

1.59

3.46

1.1

118.88

119.43

0.05

424

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

130

931

1.41

3.46

2.4

2.1

94.31

92.92

0.30

116

894

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

208

1.88

3.43

1.2

—

(3009343) pH of Capillary blood

213

1650

1.31

3.43

3.7

3.5

7.42

7.41

0.31

211

(3039744) RNA polymerase III Ab [Units/volume] in Serum

4.08

3.39

1.1

—

3.40

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.39

3.39

1.5

1.3

45.78

52.29

0.33

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

118

834

1.43

3.39

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

759

6715

1.17

3.38

5.0

4.8

1.90

2.88

ug/l

3.42

678

6013

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

206

1593

1.31

3.37

3.7

3.4

0.93

1.76

mmol/l

2.22

141

1193

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.10

3.37

1.0

1.1

—

(3039000) Anion gap in Blood

612

1.50

3.36

8.2

8.4

11.29

11.09

mmol/l

0.27

551

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

761

1.45

3.34

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

114

2.20

3.34

2.7

—

(3018572) Chloride [Moles/volume] in Blood

613

1.50

3.34

8.2

8.3

104.54

105.26

mmol/l

0.74

552

(3023430) Cat dander IgE Ab [Units/volume] in Serum

398

1.62

3.33

1.1

4.57

3.93

u/ml

0.12

143

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

314

1.70

3.32

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.79

3.25

1.9

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

198

1.88

3.24

1.2

1.0

5.91

0.78

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

499

1.53

3.16

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

104

2.22

3.15

3.1

2.7

28.35

29.27

umol/l

0.15

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

680

1.45

3.13

1.2

1.3

3.74

3.72

mmol/l

0.06

641

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

320

1.67

3.12

4.6

4.7

78.74

75.58

u/ml

0.02

(3020874) Milk IgE Ab [Units/volume] in Serum

194

1.86

3.10

1.2

1.0

0.42

3.34

u/ml

0.92

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

377

1.60

3.03

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

3.01

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

249

2004

1.26

3.01

1.8

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

1.86

3.01

1.1

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

204

1602

1.29

3.01

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.31

3.00

2.5

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.29

2.99

1.6

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

190

1.85

2.96

1.1

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.24

2.96

1.1

1.0

—

(3000012) Reticulocyte production index

356

1.61

2.96

2.0

2.2

—

(21494434) Karyotype in Bone marrow

242

1.74

2.94

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

365

1.60

2.92

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

365

1.60

2.92

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

381

1.58

2.91

2.1

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

350

1.61

2.90

1.3

1.2

—

33.67

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.44

2.87

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

367

1.59

2.86

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

207

1.80

2.86

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

329

1.62

2.83

2.2

2.1

22.88

22.98

mg/l

0.01

(3017354) Segmented neutrophils/100 leukocytes in Blood

268

1.69

2.81

4.1

3.3

59.51

55.61

0.52

228

(3002032) Base excess in Venous blood by calculation

291

2404

1.23

2.80

5.8

3.6

1.56

1.93

mmol/l

1.04

250

2039

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

521

4544

1.17

2.78

3.6

2.8

2.80

3.00

e6/l

0.11

286

2409

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

370

1.58

2.78

1.5

1.4

—

(3010421) pH of Blood

104

749

1.40

2.75

3.6

4.1

7.42

0.38

684

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

111

2.08

2.72

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

167

1.86

2.71

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

373

1.56

2.69

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

264

1.67

2.69

4.6

3.2

46.57

40.61

mg/l

0.09

190

(3030313) Adrenal Ab [Titer] in Serum

4.22

2.67

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

471

1.50

2.65

1.1

3.86

3.34

u/ml

0.16

227

(3024354) Oxygen [Partial pressure] in Venous blood

242

1974

1.24

2.63

5.1

2.9

4.59

4.64

kpa

0.15

236

1911

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

135

1022

1.33

2.63

1.3

167.62

223.33

miu/ml

1.14

511

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

491

1.48

2.57

2.2

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

362

1.56

2.56

1.1

1.0

0.38

0.20

u/ml

0.34

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

386

1.54

2.56

1.9

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

326

2753

1.20

2.53

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

159

1241

1.29

2.51

4.4

3.2

24.78

25.36

mmol/l

1.38

152

1200

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

421

1.51

2.49

1.2

21.48

28.80

u/l

0.63

364

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.11

2.48

1.2

1.3

91.71

89.06

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

202

1.74

2.48

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

302

1.60

2.47

2.3

1.6

—

(3024263) Appearance of Synovial fluid

151

1.86

2.46

1.3

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

202

1628

1.26

2.46

6.0

3.0

131.51

128.95

g/l

0.91

196

1590

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

504

1.46

2.46

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.82

2.46

1.3

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

114

851

1.35

2.46

4.2

2.5

3.45

3.56

g/l

0.41

108

801

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

682

1.39

2.42

2.1

1.5

—

(3008295) Osmolality of Serum or Plasma

304

1.59

2.41

1.5

1.4

281.24

280.02

mosm/kgh2o

0.14

238

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

490

1.46

2.41

1.9

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

204

1.72

2.40

2.2

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

384

1.52

2.40

2.8

2.4

5.43

814.13

u/ml

0.64

378

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

684

1.38

2.38

1.3

4.35

29.70

e6/l

1.98

524

(3014111) Lactate [Moles/volume] in Serum or Plasma

282

2364

1.21

2.38

7.5

6.9

1.31

1.34

mmol/l

0.18

270

2310

(3023183) Ammonium ion [Moles/volume] in Plasma

583

1.42

2.38

3.4

2.9

36.49

35.82

umol/l

0.09

536

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

685

1.38

2.37

1.4

248.50

1355.74

e6/l

1.75

554

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.42

2.36

1.4

1.2

103.40

77.00

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

113

849

1.34

2.35

3.0

2.4

181.07

182.98

0.09

104

810

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

346

1.54

2.35

1.5

1.6

51.75

59.51

0.65

214

(3029075) Extractable nuclear Ab panel - Serum

2.15

2.34

1.0

—

(3010503) CD19 cells [#/volume] in Blood

184

1.75

2.31

2.7

2.3

0.28

0.37

e9/l

0.21

179

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

159

1995

0.79

2.29

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

135

1045

1.30

2.29

2.2

1.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.38

2.29

1.2

97.00

74.95

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

245

2932

0.82

2.28

1.6

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

301

1.57

2.27

4.5

4.0

—

(3012501) Base excess in Blood by calculation

631

1.39

2.27

3.8

4.2

1.92

2.56

mmol/l

1.78

436

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

666

1.38

2.25

2.1

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

632

1.39

2.25

3.8

4.2

4.89

5.07

kpa

1.85

624

(3021788) Differential panel - Synovial fluid

523

1.42

2.24

1.4

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

154

1218

1.28

2.23

5.7

2.5

0.62

0.65

0.76

154

1210

(3006184) Hemoglobin [Mass/volume] in Capillary blood

591

1.40

2.22

1.8

2.2

129.27

129.36

g/l

0.01

437

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

319

1.54

2.21

1.3

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

635

1.38

2.19

3.8

4.2

8.96

8.54

kpa

1.49

626

(3025549) Creatine [Moles/time] in 24 hour Urine

3.34

2.18

1.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

330

1.52

2.13

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

470

1.43

2.12

1.1

66.55

21477.52

iu/ml

0.53

109

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

640

1.37

2.10

2.4

2.2

56.80

90.33

ug/min

0.70

389

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

105

1372

0.76

2.10

1.4

1.5

—

(3022313) Gas panel - Capillary blood

152

1211

1.27

2.09

4.0

3.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

206

1.66

2.07

6.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

199

1.66

2.05

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

599

5396

1.13

2.04

4.7

4.2

22.35

21.64

0.55

280

2589

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

102

774

1.33

2.03

1.3

465.50

516.48

mg/l

1.11

733

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

111

854

1.31

2.01

3.1

3.3

0.36

0.35

u/ml

0.09

488

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

319

1.51

2.00

1.2

50.93

58.59

u/l

0.77

294

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

104

1.93

2.00

1.9

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.96

2.00

1.2

1.1

90.00

87.78

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.82

2.00

1.2

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

336

1.49

1.98

2.4

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

178

1455

1.24

1.97

9.7

10.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

1.91

1.95

1.1

6.5

51.83

58.17

mg/l

0.29

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

116

902

1.30

1.95

1.5

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

133

1053

1.27

1.94

1.9

2.0

1.73

2.00

ug/l

0.14

117

937

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.75

1.93

1.0

0.05

0.08

u/ml

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

172

1.69

1.93

1.6

1.4

11.31

13.45

u/l

0.96

164

(3051611) Lipemic interference index of Serum or Plasma

290

1.52

1.92

2.5

3.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

794

0.70

1.91

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

170

1388

1.24

1.91

2.1

1.9

—

(3048879) Bone marrow aspiration report

2.06

1.90

2.0

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.96

1.89

1.3

1.8

1.31

1.34

ug/l

0.01

(3040151) Glucose [Moles/volume] in Capillary blood

291

1.52

1.89

2.7

5.2

7.55

7.19

mmol/l

0.30

241

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

154

1246

1.25

1.88

5.6

2.5

1.19

1.22

0.12

154

1236

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

324

1.49

1.88

2.2

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

324

1.49

1.88

2.2

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

136

1.77

1.87

1.1

1947.12

1448.22

miu/ml

1.32

136

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.65

1.86

1.1

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

561

1.36

1.84

1.8

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

3.53

1.83

6.0

3.1

19.00

17.01

g/mol

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.27

1.80

1.2

1.1

7.88

7.65

mg/g

0.05

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

461

1.40

1.80

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

461

1.40

1.80

1.1

—

(3000991) Gas panel - Venous blood

258

2208

1.18

1.80

9.5

8.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

598

1.35

1.79

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

138

1.74

1.79

1.2

1.3

4.51

4.39

umol/l

0.07

130

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.76

1.79

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

429

1.41

1.76

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

125

996

1.26

1.76

2.8

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

629

0.68

1.76

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

480

1.38

1.76

2.9

2.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

1.87

1.76

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

102

1.87

1.76

1.6

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

1.74

1.3

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

281

1.50

1.74

1.9

2.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.74

2.0

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

593

1.34

1.73

2.3

3.5

115.60

775.33

u/ml

0.88

550

(3003181) Sodium [Moles/volume] in Urine

482

1.38

1.72

1.4

60.25

62.60

mmol/l

0.18

389

(3036525) Urea [Moles/time] in 24 hour Urine

3.85

1.71

2.6

2.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

577

1.34

1.71

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

577

1.34

1.71

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

103

1.85

1.71

1.3

2.0

161.79

168.45

0.14

(40767503) Oxygen content in Capillary blood by calculation

578

1.34

1.70

2.4

2.5

16.74

16.25

0.43

285

(3017704) Immunofixation for Urine

149

1.68

1.66

1.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

609

0.69

1.66

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

180

1.62

1.66

1.2

11.13

19.31

u/l

1.51

155

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.16

1.66

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

119

1.77

1.66

2.0

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

317

0.57

1.65

1.1

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

104

818

1.28

1.65

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

453

1.38

1.63

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

605

0.69

1.61

1.4

—

(3028433) Virus identified in Specimen by Culture

1.84

1.61

1.1

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.33

1.58

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.82

1.57

2.3

1.3

—

(4281824) Cell count and differential, peritoneal fluid

374

0.61

1.57

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

128

1041

1.24

1.55

4.2

3.6

24.42

24.90

mmol/l

1.22

119

966

(3038177) Helicobacter pylori Ab [Presence] in Serum

527

1.33

1.54

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

145

1.66

1.54

1.2

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

100

1.80

1.52

1.3

2.1

—

31240.00

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

476

1.35

1.52

2.1

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

476

1.35

1.52

2.1

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

185

1.57

1.51

1.2

74.29

79.54

u/l

0.21

162

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

735

0.73

1.51

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

183

0.49

1.50

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.86

1.50

1.1

1.4

142.95

128.70

nmol/l

0.10

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

734

0.73

1.50

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

574

1.31

1.48

2.9

2.1

0.84

0.82

nmol/l

0.07

483

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.44

1.47

15.0

11.8

4.72

5.86

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

732

0.73

1.47

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

731

0.73

1.46

1.3

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

235

1.49

1.46

2.1

1.9

3.75

3.91

mg/l

0.09

225

(3044290) Cell count panel - Cerebral spinal fluid

638

1.29

1.45

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

472

1.34

1.45

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1006

9478

1.09

1.42

2.5

2.3

—

(21494755) Public health laboratory ask at order entry panel

275

3120

0.87

1.41

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

213

1.51

1.40

1.8

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

197

1.53

1.40

1.6

5.48

5.54

u/l

0.01

165

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.18

1.40

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

158

1.59

1.37

1.7

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

1.72

1.33

1.1

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.78

1.33

3.3

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.97

1.32

1.1

0.63

0.68

umol/24h

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

136

1.62

1.32

2.0

1.9

—

(3001729) Color of Synovial fluid

2.50

1.30

1.8

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

301

1.40

1.29

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

145

1.59

1.28

10.3

5.4

31.00

54.64

u/ml

—

(3003338) MCHC [Mass/volume]

2666

26113

1.08

1.28

22.6

16.7

331.98

332.03

g/l

0.12

2652

25934

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

400

3627

1.12

1.27

4.6

4.3

32.19

32.57

0.31

317

2499

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1.49

1.27

2.9

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.05

1.26

1.0

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.05

1.26

1.2

1.0

—

(40765096) Chromosome analysis panel by Banding

1.74

1.25

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

1.24

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

262

1.42

1.22

2.9

3.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

254

1.42

1.21

1.5

1.3

1.72

1.44

nmol/l

0.63

233

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

541

1.28

1.19

1.7

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.88

1.18

11.5

7.9

—

(3024928) Oxygen saturation in Venous blood

579

1.27

1.16

8.2

2.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.4

—

113.25

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.16

0.0

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

850

1.22

1.15

2.1

2.0

2.50

4.55

iu/l

4.34

332

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

158

1.52

1.14

1.7

1.6

—

(3023410) Appearance of Cerebral spinal fluid

309

1.36

1.13

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

267

1.39

1.12

1.3

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

327

1.35

1.12

1.1

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.90

1.12

1.4

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.96

1.11

1.0

1.1

0.42

1.50

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

217

1.43

1.11

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

371

1.33

1.11

1.6

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

189

1653

1.15

1.09

7.3

7.1

24.53

24.89

mmol/l

0.77

189

1644

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

168

1.49

1.09

1.1

—

(1002224) Polysomnography panel

150

1289

1.17

1.09

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.82

1.09

2.4

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

550

1.26

1.07

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

178

1.46

1.05

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.67

1.04

3.1

1.6

—

(4035726) Immunohistochemistry procedure

295

2667

1.12

1.03

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

146

1.51

1.03

1.2

1.4

5.67

4.63

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.06

1.02

3.4

2.6

—

27.24

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.84

1.02

12.5

8.0

—

(3016879) Cocaine [Presence] in Urine

898

0.81

1.02

1.3

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

188

1.44

1.01

1.1

0.90

1.14

u/l

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

139

1.51

1.00

1.1

129.61

182.98

iu/ml

1.07

139

(3028707) Methadone [Presence] in Urine by Screen method

436

0.73

0.98

1.3

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

3.9

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

283

1.35

0.98

1.4

—

(3000330) Specific gravity of Urine by Test strip

124

1443

0.85

0.97

4.5

3.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.80

0.96

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.80

0.96

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.80

0.96

1.4

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

174

0.57

0.96

1.7

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

424

3920

1.09

0.96

3.2

3.0

0.73

0.75

ug/l

0.11

278

2586

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

157

1.47

0.96

2.0

1.8

1.43

2.26

u/field

0.40

113

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.78

0.94

1.1

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.89

0.94

1.0

1.1

1.54

1.71

umol/24h

—

(3020393) Adenovirus Ag [Presence] in Stool

2.22

0.93

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

260

1.35

0.93

1.4

12988.87

98334.50

e6/l

1.85

149

(3014051) Protein [Presence] in Urine by Test strip

810

0.81

0.93

3.6

2.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

666

0.79

0.92

1.3

1.5

—

(4034850) Laboratory test

116

994

1.17

0.91

10.7

8.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

134

1.50

0.91

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

134

1.50

0.91

1.8

1.3

142.60

156.30

mmol/24h

0.35

134

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

134

1.50

0.91

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.86

0.87

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

1.44

0.85

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.94

0.84

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.59

0.84

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.78

0.84

1.3

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

162

1.42

0.84

1.1

1.4

144.39

133.99

nmol/l

0.35

162

(40768441) Liver Pathology biopsy report

231

1.34

0.82

1.3

—

(3036180) Methadone [Presence] in Urine

114

0.53

0.82

1.8

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

212

1911

1.12

0.82

2.3

3.3

40.62

53.24

u/ml

0.55

202

1844

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

146

1.44

0.82

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.69

0.82

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

163

1.41

0.82

2.2

2.0

4.20

2.53

ug/l

0.81

139

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.65

0.81

1.3

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.55

0.81

2.2

1.9

—

(3035880) pH of Pleural fluid

130

1.46

0.80

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

1.38

0.79

1.7

1.5

—

(40768800) Prostate Pathology biopsy report

430

0.77

0.79

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.82

0.79

4.0

9.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

1.6

1.1

—

(3042517) Benzodiazepines panel - Urine

2.08

0.74

1.0

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

342

1.26

0.74

1.1

—

4.64

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

351

1.26

0.74

1.1

—

(3027944) Amphetamines [Presence] in Urine

970

0.85

0.74

1.3

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.84

0.73

2.7

1.1

0.39

0.26

nmol/l

—

(40757373) Influenza virus identified in Isolate

1.64

0.73

3.0

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

415

1.23

0.73

1.3

7.54

7.42

mmol/l

0.07

369

(3016038) Potassium [Moles/volume] in Urine

176

1.37

0.72

1.2

1.1

34.37

34.75

mmol/l

0.02

156

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.80

0.72

4.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

237

1.31

0.72

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.58

0.71

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.37

0.71

1.1

—

(4212803) Bone marrow aspirate examination

1.92

0.70

1.4

1.1

—

(3022621) pH of Urine by Test strip

213

1943

1.10

0.69

3.3

2.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.51

0.69

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.67

0.68

9.9

7.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

137

1221

1.13

0.68

1.8

1.7

3.77

3.81

mg/l

0.02

119

896

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

347

1.24

0.67

7.0

6.8

11.51

11.58

mg/l

0.04

324

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

121

0.58

0.67

2.1

2.5

—

(3016750) Collection duration of Urine

162

1.36

0.66

2.3

2.0

494.54

490.15

min

0.10

121

(3000764) Benzodiazepines [Presence] in Urine

980

0.86

0.65

1.3

1.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

905

0.86

0.65

1.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

989

0.87

0.64

1.3

1.9

—

(3050794) Legionella sp Ab [Presence] in Serum

1.73

0.64

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.73

0.64

1.4

42.20

44.48

umol/l

—

(3051651) Icteric interference index of Serum or Plasma

172

1.34

0.63

2.8

3.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

178

1619

1.10

0.63

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

190

1.32

0.62

1.9

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.52

0.62

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

270

1.26

0.62

1.4

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

324

1.24

0.62

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

786

1.15

0.62

1.2

—

(3027008) Opiates [Presence] in Urine

985

0.87

0.62

1.3

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.63

0.62

1.6

2.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.67

0.61

1.4

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

253

1.27

0.61

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

253

1.27

0.61

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

253

1.27

0.61

1.7

1.6

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

7.99

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

36.80

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

20.58

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

183

1.31

0.59

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

757

0.86

0.59

1.3

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

327

3067

1.07

0.58

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

184

1.31

0.57

1.1

1.2

—

(3019977) pH of Arterial blood

149

1.34

0.57

1.9

2.8

7.42

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

507

0.83

0.57

1.4

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

131

1180

1.11

0.57

1.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

633

1.16

0.57

4.0

3.4

23.57

24.94

mg/l

0.15

394

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.56

1.5

2.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.62

0.55

1.5

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

206

0.73

0.55

1.4

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.58

0.54

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

285

1.23

0.54

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.48

0.53

1.9

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

620

1.15

0.52

1.7

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

360

1.20

0.51

1.7

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

112

1008

1.11

0.51

3.5

3.4

103.04

1610.97

u/ml

0.88

859

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.41

0.51

1.7

1.4

12.44

21.79

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.49

0.49

1.0

—

(3006270) Folate [Moles/volume] in Blood

252

1.23

0.49

1.3

1.1

329.79

388.58

nmol/l

1.27

228

(3005011) Chlamydia sp Ab [Titer] in Serum

1.56

0.49

2.1

1.6

—

(3012441) Differential panel - Pleural fluid

244

1.23

0.48

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

235

1.24

0.48

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

299

1.21

0.47

1.7

—

(3044007) Cell count panel - Peritoneal fluid

1.40

0.44

2.1

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

256

1.21

0.44

1.2

1.3

8.68

8.98

mmol/l

0.16

250

(3024869) Neuronal Ab [Presence] in Serum

1.37

0.44

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

220

1.23

0.43

2.5

2.1

741.06

600.53

0.68

147

(1617658) Protocol used for examination of sentinel lymph nodes

285

0.81

0.43

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

202

1.24

0.43

1.0

1.1

6.42

10.22

iu/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

202

1.24

0.43

1.3

1.5

75.88

77.50

umol/l

0.12

202

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.43

0.42

1.7

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

267

1.20

0.42

2.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

203

1.23

0.42

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

149

1.28

0.41

1.6

1.4

1.31

1.23

nmol/l

0.10

121

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.41

0.0

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.33

0.40

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

0.75

0.39

1.0

1.6

—

(3034426) Prothrombin time (PT)

106

1.32

0.39

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

383

1.15

0.37

1.2

1.4

2.28

3.99

ug/l

1.39

334

(40768793) Breast Pathology biopsy report

839

1.10

0.37

1.2

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.35

0.37

1.2

—

(3045788) Cell count panel - Pleural fluid

235

1.19

0.36

1.3

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

190

1.21

0.34

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

222

0.81

0.34

1.1

1.3

1.47

1.60

g/l

1.18

222

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.37

0.34

1.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.34

0.34

1.5

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.34

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.34

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

538

1.12

0.34

1.5

1.4

0.31

0.38

nmol/l

0.55

415

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.33

0.33

1.2

2.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

132

0.76

0.32

1.2

1.9

—

(3017569) Oxygen content in Arterial blood

137

1.24

0.32

1.7

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

128

1.25

0.32

4.2

3.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

115

1070

1.08

0.31

1.7

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

401

0.87

0.31

1.8

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.32

0.30

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

120

1.25

0.30

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.31

0.30

1.3

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

314

0.86

0.29

4.5

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

307

1.14

0.28

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

507

1.11

0.28

1.1

—

(3047189) Immunofixation for 24 hour Urine

140

1.22

0.27

1.5

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

509

1.10

0.27

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.21

0.26

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.30

0.26

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

148

1404

1.06

0.25

8.7

9.6

24.03

24.31

mmol/l

0.48

142

1371

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

581

0.91

0.25

1.8

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

207

1.16

0.25

3.2

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

1.28

0.23

4.0

6.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.24

0.23

1.7

2.2

3955.14

23890.93

e6/l

—

(3014271) Vancomycin [Susceptibility]

116

1.21

0.22

3.1

2.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

107

1.22

0.21

1.1

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

104

0.77

0.21

1.9

2.4

106.00

151.97

nmol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.16

0.21

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

145

1.17

0.20

1.3

1.4

197.95

158.63

pmol/l

1.09

145

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

261

0.88

0.20

1.5

0.89

0.96

g/l

0.94

261

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.20

0.0

1.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3011288) Drugs identified in Urine by Screen method

674

0.93

0.19

1.5

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

813

1.06

0.18

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

1.18

0.17

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

1.18

0.17

1.6

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.21

0.17

2.7

2.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.15

0.17

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

129

1.16

0.17

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.20

0.16

1.5

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.15

0.15

1.8

1.4

2.90

3.21

mmol/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

410

1.07

0.15

4.1

5.4

332.15

369.74

umol/l

0.97

354

(3001019) Free T4 and TSH panel - Serum or Plasma

187

1925

0.97

0.14

1.7

—

(1761868) Lipid panel - Serum or Plasma

1142

11319

1.01

0.13

3.0

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

169

0.89

0.12

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

219

1.10

0.12

2.3

1.6

6.93

6.77

mmol/l

0.08

147

(40768806) Pleura Pathology biopsy report

259

1.08

0.11

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

230

0.91

0.11

2.1

3.00

1.78

u/field

0.57

100

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

1.14

0.11

1.0

—

(3025130) Human papilloma virus identified in Specimen

514

1.05

0.11

1.4

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.14

0.10

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.11

0.09

2.0

2.2

1.19

1.20

mmol/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

155

1.10

0.09

1.1

1.3

—

67.59

—

(3035933) Granulocytes/100 leukocytes in Blood

1.13

0.09

1.5

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

0.90

0.08

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

127

1.10

0.07

9.1

10.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.86

0.07

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

727

7215

1.01

0.07

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

449

0.96

0.07

1.4

1.5

—

(4146454) Self-monitoring of blood glucose

286

0.94

0.07

2.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.85

0.07

1.1

1.4

18.43

17.27

umol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.07

0.07

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

670

1.03

0.06

5.0

4.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

820

1.02

0.06

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

844

8395

1.01

0.05

1.4

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.11

0.05

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.11

0.05

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

303

3002

1.01

0.05

3.4

4.0

5.67

32.70

ug/l

1.58

230

2392

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

160

0.94

0.04

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

129

0.93

0.03

2.1

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

122

1.07

0.02

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

128

0.94

0.02

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

128

0.94

0.02

1.9

1.8

—

(3011648) Oxygen content in Venous blood

233

1.03

0.01

2.7

2.2

12.07

11.10

0.55

233

(3044242) Glucose [Moles/volume] in Arterial blood

144

1.04

0.00

2.1

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

1.04

0.00

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

1.04

0.00

1.8

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

156

0.96

0.00

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

194

1.03

0.00

1.0

348.07

331.56

ng/l

0.08

131

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

194

1.03

0.00

1.0

721.50

718.36

ng/l

0.01

128

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

131

1315

1.00

0.00

1.3

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

309

1.00

0.00

1.7

1.8

14.50

24.40

ug/l

1.72

304

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

196

1.02

0.00

1.0

52.58

47.15

ng/l

0.19

128

(3004451) EKG impression Narrative

134

0.97

0.00

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

486

1.01

0.00

3.1

0.80

0.81

nmol/l

0.09

374

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

183

0.98

0.00

1.1

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.95

0.00

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

-0.00

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.96

-0.00

1.2

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.35

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.47

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

357.43

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

300

1.00

-0.00

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.93

-0.00

1.0

1.2

—

8.00

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.02

-0.00

1.0

1.4

—

(3006462) Nitrate [Presence] in Urine

140

1.00

-0.00

5.0

3.3

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

65.38

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ROSACEANAS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_ROSACEANAS	1.025 [0.91, 1.15]	0.679
Birth year	0.993 [0.98, 1.0]	0.116

During the follow-up period (1.1.1998 — 31.12.2019), 841 out of 9572 females with L12_ROSACEANAS died.

Males

Parameter	HR [95% CI]	p-value
L12_ROSACEANAS	1.159 [1.02, 1.31]	0.02
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 934 out of 4958 males with L12_ROSACEANAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_ROSACEANAS.

N-year risk	Females	Males
1	0.13%	0.201%
5	0.63%	1.099%
10	1.48%	2.94%
15	3.042%	5.396%
20	4.96%	9.137%

Relationships between endpoints

↥

Index endpoint: L12_ROSACEANAS – Other and unspecified rosacea

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified rosacea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints